These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
x
|
Annual Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For the fiscal year ended March 31, 2017
|
|
o
|
Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For the transition period from _________ to __________
|
|
Delaware
|
|
86-0629024
|
|
(State or Other Jurisdiction of Incorporation or Organization)
|
|
(IRS Employer Identification No.)
|
|
Title of Each Class
|
|
Name of Each Exchange on Which Registered
|
|
Common Stock, $0.001 Par Value Per Share
|
|
NASDAQ® Global Market
|
|
Large accelerated filer
|
x
|
Accelerated filer
|
o
|
Non-accelerated filer
|
o
|
(Do not check if a smaller reporting company)
|
|
|
|
|
|
|
|
|
Smaller reporting company
|
o
|
|
|
|
|
|
|
|
Emerging growth company
|
o
|
|
Documents Incorporated by Reference
|
||
|
Document
|
|
Part of Form 10-K
|
|
Proxy Statement for the 2017 Annual Meeting of Stockholders
|
|
III
|
|
|
|
Page
|
|
|
|
|
|
PART I
|
||
|
|
|
|
|
|
|
|
|
PART II
|
||
|
|
|
|
|
PART III
|
||
|
|
|
|
|
|
|
|
|
PART IV
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
•
|
our annual report on Form 10-K
|
|
•
|
our quarterly reports on Form 10-Q
|
|
•
|
our current reports on Form 8-K
|
|
•
|
our proxy statement
|
|
•
|
any amendments to the above-listed reports filed or furnished pursuant to Sections 13(a) or 15(d) of the Securities Exchange Act of 1934
|
|
•
|
differentiate their products
|
|
•
|
replace less efficient electromechanical control devices
|
|
•
|
reduce the number of components in their system
|
|
•
|
add product functionality
|
|
•
|
reduce the system level energy consumption
|
|
•
|
make systems safer to operate
|
|
•
|
decrease time to market for their products
|
|
•
|
significantly reduce product cost
|
|
•
|
automotive comfort, safety, information and entertainment applications
|
|
•
|
remote control devices
|
|
•
|
handheld tools
|
|
•
|
large and small home appliances
|
|
•
|
portable computers and accessories
|
|
•
|
robotics
|
|
•
|
energy monitoring
|
|
•
|
thermostats
|
|
•
|
motor controls
|
|
•
|
security systems
|
|
•
|
smoke and carbon monoxide detectors
|
|
•
|
consumer electronics
|
|
•
|
power supplies
|
|
•
|
applications needing touch buttons, touch screens and graphical user interfaces
|
|
•
|
medical instruments
|
|
•
|
general purpose and specialized microcontrollers and 32-bit microprocessors
|
|
•
|
development tools and related software
|
|
•
|
analog, interface, mixed signal, timing and security products
|
|
•
|
wired and wireless connectivity products
|
|
•
|
memory products
|
|
•
|
technology licensing
|
|
•
|
Tempe, Arizona (Fab 2)
|
|
•
|
Gresham, Oregon (Fab 4)
|
|
•
|
Colorado Springs, Colorado (Fab 5)
|
|
•
|
Chandler, Arizona (wafer probe)
|
|
•
|
Bangkok, Thailand (wafer probe, assembly and test)
|
|
•
|
Calamba, Philippines (wafer probe and test)
|
|
|
March 31,
|
||||||||||
|
|
2017
|
|
2016
|
|
2015
|
||||||
|
United States
|
$
|
388,537
|
|
|
$
|
373,860
|
|
|
$
|
331,372
|
|
|
Thailand
|
210,603
|
|
|
182,813
|
|
|
197,981
|
|
|||
|
Various other countries
|
84,198
|
|
|
52,723
|
|
|
52,219
|
|
|||
|
Total long-lived assets
|
$
|
683,338
|
|
|
$
|
609,396
|
|
|
$
|
581,572
|
|
|
|
|
Year Ended March 31,
|
||||||||||||||||
|
|
|
2017
|
|
%
|
|
2016
|
|
%
|
|
2015
|
|
%
|
||||||
|
Americas
|
|
$
|
641,849
|
|
|
18.8
|
|
$
|
417,579
|
|
|
19.2
|
|
$
|
421,947
|
|
|
19.7
|
|
Europe
|
|
808,583
|
|
|
23.7
|
|
474,629
|
|
|
21.8
|
|
452,165
|
|
|
21.0
|
|||
|
Asia
|
|
1,957,375
|
|
|
57.5
|
|
1,281,126
|
|
|
59.0
|
|
1,272,924
|
|
|
59.3
|
|||
|
Total Sales
|
|
$
|
3,407,807
|
|
|
100.0
|
|
$
|
2,173,334
|
|
|
100.0
|
|
$
|
2,147,036
|
|
|
100.0
|
|
•
|
performance
|
|
•
|
analog, digital and mixed signal functionality and level of functional integration
|
|
•
|
memory density
|
|
•
|
low power consumption
|
|
•
|
extended voltage ranges
|
|
•
|
reliability
|
|
•
|
packaging alternatives
|
|
•
|
complete development tool line
|
|
•
|
ease of use
|
|
•
|
functionality of application development systems
|
|
•
|
dependable delivery, quality and availability
|
|
•
|
technical and innovative service and support
|
|
•
|
time to market
|
|
•
|
price
|
|
Name
|
|
Age
|
|
Position
|
|
Steve Sanghi
|
|
61
|
|
Chief Executive Officer and Chairman of the Board
|
|
Ganesh Moorthy
|
|
57
|
|
President and Chief Operating Officer
|
|
J. Eric Bjornholt
|
|
46
|
|
Vice President, Chief Financial Officer
|
|
Stephen V. Drehobl
|
|
55
|
|
Vice President, MCU8 and Technology Development Division
|
|
Mitchell R. Little
|
|
65
|
|
Vice President, Worldwide Sales and Applications
|
|
Richard J. Simoncic
|
|
53
|
|
Vice President, Analog Power and Interface Division
|
|
•
|
general economic, industry or political conditions in the U.S. or internationally;
|
|
•
|
changes in demand or market acceptance of our products and products of our customers, and market fluctuations in the industries into which such products are sold;
|
|
•
|
changes in utilization of our manufacturing capacity and fluctuations in manufacturing yields;
|
|
•
|
our ability to realize the expected benefits of our acquisitions including our acquisition of Atmel;
|
|
•
|
our ability to ramp our factory capacity to meet customer demand;
|
|
•
|
changes or fluctuations in customer order patterns and seasonality;
|
|
•
|
our ability to secure sufficient wafer foundry, assembly and testing capacity;
|
|
•
|
the mix of inventory we hold and our ability to satisfy orders from our inventory;
|
|
•
|
levels of inventories held by our customers;
|
|
•
|
risk of excess and obsolete inventories;
|
|
•
|
changes in tax regulations and policies in the U.S. and other countries in which we do business;
|
|
•
|
competitive developments including pricing pressures;
|
|
•
|
unauthorized copying of our products resulting in pricing pressure and loss of sales;
|
|
•
|
availability of raw materials and equipment;
|
|
•
|
our ability to successfully transition products to more advanced process technologies to reduce manufacturing costs;
|
|
•
|
the level of orders that are received and can be shipped in a quarter;
|
|
•
|
the level of sell-through of our products through distribution;
|
|
•
|
fluctuations in our mix of product sales;
|
|
•
|
announcements of significant acquisitions by us or our competitors;
|
|
•
|
disruptions in our business or our customers' businesses due to terrorist activity, armed conflict, war, worldwide oil prices and supply, public health concerns, natural disasters or disruptions in the transportation system;
|
|
•
|
constrained availability from other electronic suppliers impacting our customers' ability to ship their products, which in turn may adversely impact our sales to those customers;
|
|
•
|
costs and outcomes of any current or future tax audits or any litigation involving intellectual property, customers or other issues;
|
|
•
|
fluctuations in commodity prices; and
|
|
•
|
property damage or other losses, whether or not covered by insurance.
|
|
•
|
the quality, performance, reliability, features, ease of use, pricing and diversity of our products;
|
|
•
|
our success in designing and manufacturing new products including those implementing new technologies;
|
|
•
|
the rate at which customers incorporate our products into their own applications and the success of such applications;
|
|
•
|
the rate at which the markets that we serve redesign and change their own products;
|
|
•
|
changes in demand in the markets that we serve and the overall rate of growth or contraction of such markets, including but not limited to the automotive, personal computing and consumer electronics markets;
|
|
•
|
product introductions by our competitors;
|
|
•
|
the number, nature and success of our competitors in a given market;
|
|
•
|
our ability to obtain adequate foundry and assembly and test capacity and supplies of raw materials and other supplies at acceptable prices;
|
|
•
|
our ability to ramp production and increase capacity, as needed, at our wafer fabrication and assembly and test facilities;
|
|
•
|
our ability to protect our products and processes by effective utilization of intellectual property rights;
|
|
•
|
our ability to remain price competitive against companies that have copied our proprietary product lines, especially in countries where intellectual property rights protection is difficult to achieve and maintain;
|
|
•
|
our ability to address the needs of our customers; and
|
|
•
|
general market and economic conditions.
|
|
•
|
proper new product selection;
|
|
•
|
timely completion and introduction of new product designs;
|
|
•
|
procurement of licenses for intellectual property rights from third parties under commercially reasonable terms;
|
|
•
|
timely filing and protection of intellectual property rights for new product designs;
|
|
•
|
availability of development and support tools and collateral literature that make complex new products easy for engineers to understand and use; and
|
|
•
|
market acceptance of our customers' end products.
|
|
•
|
proper identification of licensee requirements;
|
|
•
|
timely development and introduction of new or enhanced technology;
|
|
•
|
our ability to protect and enforce our intellectual property rights for our licensed technology;
|
|
•
|
our ability to limit our liability and indemnification obligations to licensees;
|
|
•
|
availability of sufficient development and support services to assist licensees in their design and manufacture of products integrating our technology;
|
|
•
|
availability of foundry licensees with sufficient capacity to support original equipment manufacturer (OEM) production; and
|
|
•
|
market acceptance of our customers' end products.
|
|
•
|
costs related to writing off the value of our inventory of nonconforming products;
|
|
•
|
recalling nonconforming products;
|
|
•
|
providing support services, product replacements, or modifications to products and the defense of such claims;
|
|
•
|
diversion of resources from other projects;
|
|
•
|
lost revenue or a delay in the recognition of revenue due to cancellation of orders or unpaid receivables;
|
|
•
|
customer imposed fines or penalties for failure to meet contractual requirements; and
|
|
•
|
a requirement to pay damages or penalties.
|
|
•
|
political, social and economic instability;
|
|
•
|
economic uncertainty in the worldwide markets served by us;
|
|
•
|
trade restrictions and changes in tariffs;
|
|
•
|
import and export license requirements and restrictions;
|
|
•
|
changes in rules and laws related to taxes, environmental, health and safety, technical standards and consumer protection in various jurisdictions;
|
|
•
|
currency fluctuations and foreign exchange regulations;
|
|
•
|
difficulties in staffing and managing international operations;
|
|
•
|
employment regulations;
|
|
•
|
disruptions in international transport or delivery;
|
|
•
|
public health conditions;
|
|
•
|
difficulties in collecting receivables and longer payment cycles; and
|
|
•
|
potentially adverse tax consequences.
|
|
•
|
quarterly variations in our operating results or the operating results of other technology companies;
|
|
•
|
general conditions in the semiconductor industry;
|
|
•
|
global economic and financial conditions;
|
|
•
|
changes in our financial guidance or our failure to meet such guidance;
|
|
•
|
changes in analysts' estimates of our financial performance or buy/sell recommendations;
|
|
•
|
any acquisitions we pursue or complete; and
|
|
•
|
actual or anticipated announcements of technical innovations or new products by us or our competitors.
|
|
•
|
the ability of our board of directors to issue shares of preferred stock and to determine the price and other terms of those shares, including preferences and voting rights, without stockholder approval, which could be used to significantly dilute the ownership of a hostile acquiror;
|
|
•
|
the right of our board of directors to elect a director to fill a vacancy created by the expansion of our board of directors or the resignation, death or removal of a director, which prevents stockholders from being able to fill vacancies on our board of directors;
|
|
•
|
the requirement that a special meeting of stockholders may be called only by the holders of 50% or more of the combined voting power of all classes of our capital stock, which could delay the ability of our stockholders to force consideration of a proposal or to take action, including the removal of directors;
|
|
•
|
the ability of our board of directors, by majority vote, to amend the bylaws, which may allow our board of directors to take additional actions to prevent an unsolicited takeover and inhibit the ability of an acquiror to amend the bylaws to facilitate an unsolicited takeover attempt; and
|
|
•
|
advance notice procedures with which stockholders must comply to nominate candidates to our board of directors or to propose matters to be acted upon at a stockholders' meeting, which may discourage or deter a potential acquiror from conducting a solicitation of proxies to elect the acquiror's own slate of directors or otherwise attempting to obtain control of us.
|
|
Location
|
|
Approximate
Total Sq. Ft.
|
|
Uses
|
|
Gresham, Oregon
|
|
826,500
|
|
Wafer Fabrication (Fab 4); R&D Center; Administrative Offices; and Warehousing
|
|
Chacherngsao, Thailand
|
|
489,000
|
|
Assembly and Test; Wafer Probe; Sample Center; Warehousing; and Administrative Offices
|
|
Colorado Springs, Colorado
|
|
480,000
|
|
Manufacturing, Test, Research and Development, Computer and Service Functions, Design and Engineering
|
|
Calamba, Philippines
|
|
460,000
|
|
Wafer Probe, Test and Administrative Offices
|
|
Tempe, Arizona
|
|
457,000
|
|
Wafer Fabrication (Fab 2); R&D Center; Administrative Offices; and Warehousing
|
|
Chandler, Arizona
|
|
415,000
|
|
Executive and Administrative Offices; Wafer Probe; R&D Center; Sales and Marketing; and Computer and Service Functions
|
|
Bangalore, India
|
|
281,000
|
|
Research and Development; Sales and Marketing Support, and Administrative Offices
|
|
Chacherngsao, Thailand
|
|
215,000
|
|
Assembly and Test
|
|
Rousset, France
|
|
170,000
|
|
Design, Engineering, Test and Administrative
|
|
Nantes, France
|
|
77,000
|
|
Design, Engineering, Test and Probe, Administrative and Warehousing
|
|
Shanghai, China
|
|
21,000
|
|
Research and Development; Marketing Support, and Administrative Offices
|
|
Hsinchu, Taiwan
|
|
15,000
|
|
Design, Engineering and Administrative
|
|
Fiscal 2017
|
|
High
|
|
Low
|
|
Fiscal 2016
|
|
High
|
|
Low
|
||||||||
|
First Quarter
|
|
$
|
52.99
|
|
|
$
|
47.16
|
|
|
First Quarter
|
|
$
|
50.41
|
|
|
$
|
46.66
|
|
|
Second Quarter
|
|
62.80
|
|
|
49.49
|
|
|
Second Quarter
|
|
46.64
|
|
|
39.57
|
|
||||
|
Third Quarter
|
|
66.18
|
|
|
58.41
|
|
|
Third Quarter
|
|
49.11
|
|
|
42.19
|
|
||||
|
Fourth Quarter
|
|
74.52
|
|
|
62.59
|
|
|
Fourth Quarter
|
|
49.11
|
|
|
39.65
|
|
||||
|
|
|
Cumulative Total Return
|
||||||||||
|
|
|
March 2012
|
|
March 2013
|
|
March 2014
|
|
March 2015
|
|
March 2016
|
|
March 2017
|
|
Microchip Technology Incorporated
|
|
100.00
|
|
103.11
|
|
138.65
|
|
146.35
|
|
148.88
|
|
233.40
|
|
S&P 500 Stock Index
|
|
100.00
|
|
113.96
|
|
138.87
|
|
156.55
|
|
159.34
|
|
186.71
|
|
Philadelphia Semiconductor Index
|
|
100.00
|
|
100.34
|
|
129.24
|
|
150.30
|
|
149.32
|
|
209.36
|
|
Fiscal 2017
|
|
Dividends per Common Share
|
|
Aggregate
Amount of
Dividend
Payment
|
|
Fiscal 2016
|
|
Dividends per Common Share
|
|
Aggregate
Amount of
Dividend
Payment
|
||||||||
|
First Quarter
|
|
$
|
0.3595
|
|
|
$
|
77,237
|
|
|
First Quarter
|
|
$
|
0.3575
|
|
|
$
|
72,331
|
|
|
Second Quarter
|
|
0.3600
|
|
|
77,640
|
|
|
Second Quarter
|
|
0.3580
|
|
|
72,686
|
|
||||
|
Third Quarter
|
|
0.3605
|
|
|
77,970
|
|
|
Third Quarter
|
|
0.3585
|
|
|
72,923
|
|
||||
|
Fourth Quarter
|
|
0.3610
|
|
|
82,582
|
|
|
Fourth Quarter
|
|
0.3590
|
|
|
73,147
|
|
||||
|
|
|
Year ended March 31,
|
||||||||||||||||||
|
|
|
2017
(1)
|
|
2016
(1)
|
|
2015
(1)
|
|
2014
|
|
2013
|
||||||||||
|
Net sales
|
|
$
|
3,407,807
|
|
|
$
|
2,173,334
|
|
|
$
|
2,147,036
|
|
|
$
|
1,931,217
|
|
|
$
|
1,581,623
|
|
|
Cost of sales
|
|
1,650,611
|
|
|
967,870
|
|
|
917,472
|
|
|
802,474
|
|
|
743,164
|
|
|||||
|
Research and development
|
|
545,293
|
|
|
372,596
|
|
|
349,543
|
|
|
305,043
|
|
|
254,723
|
|
|||||
|
Selling, general and administrative
|
|
499,811
|
|
|
301,670
|
|
|
274,815
|
|
|
267,278
|
|
|
261,471
|
|
|||||
|
Amortization of acquired intangible assets
|
|
337,667
|
|
|
174,896
|
|
|
176,746
|
|
|
94,534
|
|
|
111,537
|
|
|||||
|
Special charges and other, net
(2)
|
|
98,608
|
|
|
3,957
|
|
|
2,840
|
|
|
3,024
|
|
|
32,175
|
|
|||||
|
Operating income
|
|
275,817
|
|
|
352,345
|
|
|
425,620
|
|
|
458,864
|
|
|
178,553
|
|
|||||
|
Losses on equity method investments
|
|
(222
|
)
|
|
(345
|
)
|
|
(317
|
)
|
|
(177
|
)
|
|
(617
|
)
|
|||||
|
Interest income
|
|
3,079
|
|
|
24,447
|
|
|
19,527
|
|
|
16,485
|
|
|
15,560
|
|
|||||
|
Interest expense
|
|
(146,346
|
)
|
|
(104,018
|
)
|
|
(62,034
|
)
|
|
(48,716
|
)
|
|
(40,915
|
)
|
|||||
|
Loss on settlement of convertible debt
(3)
|
|
(43,879
|
)
|
|
—
|
|
|
(50,631
|
)
|
|
—
|
|
|
—
|
|
|||||
|
Other income (loss), net
|
|
1,338
|
|
|
8,864
|
|
|
13,742
|
|
|
5,898
|
|
|
(404
|
)
|
|||||
|
Income from continuing operations before income taxes
|
|
89,787
|
|
|
281,293
|
|
|
345,907
|
|
|
432,354
|
|
|
152,177
|
|
|||||
|
Income tax (benefit) provision
|
|
(80,805
|
)
|
|
(42,632
|
)
|
|
(19,418
|
)
|
|
37,073
|
|
|
24,788
|
|
|||||
|
Net income from continuing operations
|
|
170,592
|
|
|
323,925
|
|
|
365,325
|
|
|
395,281
|
|
|
127,389
|
|
|||||
|
Less: Net loss attributable to noncontrolling interests
|
|
—
|
|
|
207
|
|
|
3,684
|
|
|
—
|
|
|
—
|
|
|||||
|
Net income from continuing operations attributable to Microchip Technology
|
|
$
|
170,592
|
|
|
$
|
324,132
|
|
|
$
|
369,009
|
|
|
$
|
395,281
|
|
|
$
|
127,389
|
|
|
Basic net income per common share from continuing operations attributable to Microchip Technology stockholders
|
|
$
|
0.79
|
|
|
$
|
1.59
|
|
|
$
|
1.84
|
|
|
$
|
1.99
|
|
|
$
|
0.65
|
|
|
Diluted net income per common share from continuing operations attributable to Microchip Technology stockholders
|
|
$
|
0.73
|
|
|
$
|
1.49
|
|
|
$
|
1.65
|
|
|
$
|
1.82
|
|
|
$
|
0.62
|
|
|
Dividends declared per common share
|
|
$
|
1.441
|
|
|
$
|
1.433
|
|
|
$
|
1.425
|
|
|
$
|
1.417
|
|
|
$
|
1.406
|
|
|
Basic common shares outstanding
|
|
217,196
|
|
|
203,384
|
|
|
200,937
|
|
|
198,291
|
|
|
194,595
|
|
|||||
|
Diluted common shares outstanding
|
|
234,806
|
|
|
217,388
|
|
|
223,561
|
|
|
217,630
|
|
|
205,776
|
|
|||||
|
(1)
|
Refer to Note 2 to our consolidated financial statements for an explanation of our material business combinations during fiscal 2017, fiscal 2016, and fiscal 2015.
|
|
|
|
March 31,
|
||||||||||||||||||
|
|
|
2017
|
|
2016
|
|
2015
|
|
2014
|
|
2013
|
||||||||||
|
Acquisition related expenses
|
|
$
|
98,608
|
|
|
$
|
11,163
|
|
|
$
|
2,840
|
|
|
$
|
1,654
|
|
|
$
|
16,259
|
|
|
Legal settlement
|
|
—
|
|
|
(7,206
|
)
|
|
—
|
|
|
—
|
|
|
11,516
|
|
|||||
|
Adjustment to contingent consideration
|
|
—
|
|
|
—
|
|
|
—
|
|
|
1,370
|
|
|
4,400
|
|
|||||
|
Totals
|
|
$
|
98,608
|
|
|
$
|
3,957
|
|
|
$
|
2,840
|
|
|
$
|
3,024
|
|
|
$
|
32,175
|
|
|
|
|
March 31,
|
||||||||||||||||||
|
|
|
2017
|
|
2016
|
|
2015
|
|
2014
|
|
2013
|
||||||||||
|
Working capital
|
|
$
|
1,600,590
|
|
|
$
|
2,714,704
|
|
|
$
|
2,310,645
|
|
|
$
|
1,633,320
|
|
|
$
|
1,894,759
|
|
|
Total assets
|
|
7,686,881
|
|
|
5,537,883
|
|
|
4,780,713
|
|
|
4,067,630
|
|
|
3,851,405
|
|
|||||
|
Long-term obligations, less current portion
|
|
2,900,524
|
|
|
2,453,405
|
|
|
1,826,858
|
|
|
1,003,258
|
|
|
983,385
|
|
|||||
|
Microchip Technology Stockholders' equity
|
|
3,270,711
|
|
|
2,150,919
|
|
|
2,044,654
|
|
|
2,135,461
|
|
|
1,933,470
|
|
|||||
|
Item 7.
|
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
|
|
•
|
The effects that adverse global economic conditions and fluctuations in the global credit and equity markets may have on our financial condition and results of operations;
|
|
•
|
The effects and amount of competitive pricing pressure on our product lines;
|
|
•
|
Our ability to moderate future average selling price declines;
|
|
•
|
The effect of product mix, capacity utilization, yields, fixed cost absorption, competition and economic conditions on gross margin;
|
|
•
|
The amount of, and changes in, demand for our products and those of our customers;
|
|
•
|
Our expectation that in the future we will acquire additional businesses that we believe will complement our existing businesses;
|
|
•
|
Our expectation that in the future we will enter into joint development agreements or other business or strategic relationships with other companies;
|
|
•
|
The level of orders that will be received and shipped within a quarter;
|
|
•
|
Our expectation that our days of inventory levels in the June 2017 quarter will be 97 days to 106 days. Our belief that our existing level of inventory will allow us to maintain competitive lead times and provide strong delivery performance to our customers;
|
|
•
|
The effect that distributor and customer inventory holding patterns will have on us;
|
|
•
|
Our belief that customers recognize our products and brand name and use distributors as an effective supply channel;
|
|
•
|
Anticipating increased customer requirements to meet voluntary criteria related to the reduction or elimination of substances in our products;
|
|
•
|
Our belief that deferred cost of sales are recorded at their approximate carrying value and will have low risk of material impairment;
|
|
•
|
Our belief that our direct sales personnel combined with our distributors provide an effective means of reaching our customer base;
|
|
•
|
Our ability to increase the proprietary portion of our analog and interface product lines and the effect of such an increase;
|
|
•
|
Our belief that our processes afford us both cost-effective designs in existing and derivative products and greater functionality in new product designs;
|
|
•
|
The impact of any supply disruption we may experience;
|
|
•
|
Our ability to effectively utilize our facilities at appropriate capacity levels and anticipated costs;
|
|
•
|
That we adjust capacity utilization to respond to actual and anticipated business and industry-related conditions;
|
|
•
|
That our existing facilities will provide sufficient capacity to respond to increases in demand with modest incremental capital expenditures;
|
|
•
|
That manufacturing costs will be reduced by transition to advanced process technologies;
|
|
•
|
Our ability to maintain manufacturing yields;
|
|
•
|
Continuing our investments in new and enhanced products;
|
|
•
|
The cost effectiveness of using our own assembly and test operations;
|
|
•
|
Our anticipated level of capital expenditures;
|
|
•
|
Continuation and amount of quarterly cash dividends;
|
|
•
|
The sufficiency of our existing sources of liquidity to finance anticipated capital expenditures and otherwise meet our anticipated cash requirements, and the effects that our contractual obligations are expected to have on them;
|
|
•
|
That our U.S. operations and capital requirements are funded primarily by cash generated from U.S. operating activities, which has been and is expected to be sufficient to meet our business needs in the U.S. for the foreseeable future;
|
|
•
|
The impact of seasonality on our business;
|
|
•
|
The accuracy of our estimates used in valuing employee equity awards;
|
|
•
|
That the resolution of legal actions will not have a material effect on our business, and the accuracy of our assessment of the probability of loss and range of potential loss;
|
|
•
|
The recoverability of our deferred tax assets;
|
|
•
|
The adequacy of our tax reserves to offset any potential tax liabilities, having the appropriate support for our income tax positions and the accuracy of our estimated tax rate;
|
|
•
|
Our belief that our determinations with respect to the tax consequences of the Atmel acquisition are reasonable;
|
|
•
|
Our belief that the expiration of any tax holidays will not have a material impact on our overall tax expense or effective tax rate;
|
|
•
|
Our belief that the estimates used in preparing our consolidated financial statements are reasonable;
|
|
•
|
Our belief that some of the recently issued accounting pronouncements listed in this document will not have a material impact on our consolidated financial statements;
|
|
•
|
The accuracy of our estimates of the useful life and values of our property, assets and other liabilities;
|
|
•
|
The adequacy of our patent strategy, and our belief that the impact of the expiration of any particular patent will not have a material effect on our business;
|
|
•
|
Our actions to vigorously and aggressively defend and protect our intellectual property on a worldwide basis;
|
|
•
|
Our ability to obtain patents and intellectual property licenses and minimize the effects of litigation;
|
|
•
|
The level of risk we are exposed to for product liability claims or indemnification claims;
|
|
•
|
The effect of fluctuations in market interest rates on our income and/or cash flows;
|
|
•
|
The effect of fluctuations in currency rates;
|
|
•
|
That our offshore earnings are considered to be permanently reinvested offshore and that we could determine to repatriate some of our offshore earnings in future periods to fund stockholder dividends, share repurchases, acquisitions or other corporate activities;
|
|
•
|
That a significant portion of our future cash generation will be in our foreign subsidiaries;
|
|
•
|
Our intention to satisfy the lesser of the principal amount or the conversion value of our debentures in cash;
|
|
•
|
Our intention to indefinitely reinvest undistributed earnings of certain non-US subsidiaries in those subsidiaries;
|
|
•
|
Our intent to maintain a high-quality investment portfolio that preserves principal, meets liquidity needs, avoids inappropriate concentrations and delivers an appropriate yield; and
|
|
•
|
Our ability to collect accounts receivable.
|
|
|
|
Year Ended March 31,
|
|||||||
|
|
|
2017
|
|
2016
|
|
2015
|
|||
|
Net sales
|
|
100.0
|
%
|
|
100.0
|
%
|
|
100.0
|
%
|
|
Cost of sales
|
|
48.4
|
|
|
44.5
|
|
|
42.7
|
|
|
Gross profit
|
|
51.6
|
|
|
55.5
|
|
|
57.3
|
|
|
Research and development
|
|
16.0
|
|
|
17.1
|
|
|
16.3
|
|
|
Selling, general and administrative
|
|
14.7
|
|
|
13.9
|
|
|
12.8
|
|
|
Amortization of acquired intangible assets
|
|
9.9
|
|
|
8.1
|
|
|
8.3
|
|
|
Special charges and other, net
|
|
2.9
|
|
|
0.2
|
|
|
0.1
|
|
|
Operating income
|
|
8.1
|
%
|
|
16.2
|
%
|
|
19.8
|
%
|
|
•
|
our acquisition of Atmel, which closed on April 4, 2016;
|
|
•
|
our acquisition of Micrel, which closed on August 3, 2015;
|
|
•
|
global economic conditions in the markets we serve;
|
|
•
|
semiconductor industry conditions;
|
|
•
|
our acquisition of ISSC on July 17, 2014;
|
|
•
|
our acquisition of Supertex on April 1, 2014;
|
|
•
|
our new product offerings that have increased our served available market;
|
|
•
|
customers' increasing needs for the flexibility offered by our programmable solutions;
|
|
•
|
inventory holding patterns of our customers;
|
|
•
|
increasing semiconductor content in our customers' products; and
|
|
•
|
continued market share gains in the segments of the markets we address.
|
|
|
Year Ended March 31,
|
||||||||||||||||
|
|
2017
|
|
%
|
|
2016
|
|
%
|
|
2015
|
|
%
|
||||||
|
Microcontrollers
|
$
|
2,147,338
|
|
|
63.0
|
|
$
|
1,345,499
|
|
|
61.9
|
|
$
|
1,393,607
|
|
|
64.9
|
|
Analog, interface, mixed signal and timing products
|
888,878
|
|
|
26.1
|
|
595,455
|
|
|
27.4
|
|
501,048
|
|
|
23.3
|
|||
|
Memory products
|
184,107
|
|
|
5.4
|
|
116,945
|
|
|
5.4
|
|
132,258
|
|
|
6.2
|
|||
|
Technology licensing
|
91,156
|
|
|
2.7
|
|
89,124
|
|
|
4.1
|
|
89,593
|
|
|
4.2
|
|||
|
Multi-market and other
|
96,328
|
|
|
2.8
|
|
26,311
|
|
|
1.2
|
|
30,530
|
|
|
1.4
|
|||
|
Total net sales
|
$
|
3,407,807
|
|
|
100.0
|
|
$
|
2,173,334
|
|
|
100.0
|
|
$
|
2,147,036
|
|
|
100.0
|
|
|
Year Ended March 31,
|
||||||||||||||||
|
|
2017
|
|
%
|
|
2016
|
|
%
|
|
2015
|
|
%
|
||||||
|
Americas
|
$
|
641,849
|
|
|
18.8
|
|
$
|
417,579
|
|
|
19.2
|
|
$
|
421,947
|
|
|
19.7
|
|
Europe
|
808,583
|
|
|
23.7
|
|
474,629
|
|
|
21.8
|
|
452,165
|
|
|
21.0
|
|||
|
Asia
|
1,957,375
|
|
|
57.5
|
|
1,281,126
|
|
|
59.0
|
|
1,272,924
|
|
|
59.3
|
|||
|
Total net sales
|
$
|
3,407,807
|
|
|
100.0
|
|
$
|
2,173,334
|
|
|
100.0
|
|
$
|
2,147,036
|
|
|
100.0
|
|
•
|
charges of approximately $186.7 million in fiscal 2017, approximately $44.9 million in fiscal 2016, and approximately $24.4 million in fiscal 2015 related to the recognition of acquired inventory at fair value as a result of our acquisitions which increased the value of our acquired inventory and subsequently increased our cost of sales and reduced our gross margins when the related revenue was recognized;
|
|
•
|
for each of fiscal 2017, fiscal 2016 and fiscal 2015, inventory write-downs being higher than the gross margin impact of sales of inventory that was previously written down; and
|
|
•
|
fluctuations in the product mix of microcontrollers, analog, interface, mixed signal and timing products, memory products and technology licensing.
|
|
•
|
continual cost reductions in wafer fabrication and assembly and test manufacturing, such as new manufacturing technologies and more efficient manufacturing techniques; and
|
|
•
|
lower depreciation as a percentage of cost of sales.
|
|
•
|
In fiscal 2017, we issued $2,645.0 million of debt, of which $2,118.7 million was used to settle debt and reduce borrowings on our credit facility.
|
|
•
|
In fiscal 2016, we repurchased shares of our common stock for $363.8 million, which was primarily funded with borrowings on our credit facility.
|
|
•
|
In fiscal 2015, we entered into several debt transactions with a net cash inflow of $557.5 million. This included the issuance of $1,725.0 million principal amount of senior debt. The proceeds from the debt issuance were used to repay other debt and reduce borrowings on our credit facility.
|
|
•
|
In fiscal
2017
,
2016
and
2015
, we paid cash dividends to our stockholders of
$315.4 million
,
$291.1 million
, and
$286.5 million
respectively. The amount of dividends paid has increased due to an increase in the amount of dividends declared per share and in the number of shares outstanding.
|
|
|
Payments Due by Period
|
||||||||||||||||||
|
|
Total
|
|
Less than
1 year
|
|
1 – 3 years
|
|
3 – 5 years
|
|
More than
5 years
|
||||||||||
|
Operating lease obligations
(1)
|
$
|
87,399
|
|
|
$
|
26,259
|
|
|
$
|
36,034
|
|
|
$
|
22,683
|
|
|
$
|
2,423
|
|
|
Capital purchase obligations
(2)
|
45,549
|
|
|
45,549
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
|
Other purchase obligations and commitments
(3)
|
107,393
|
|
|
105,455
|
|
|
1,575
|
|
|
242
|
|
|
121
|
|
|||||
|
2017 senior debt
(4)
|
2,406,376
|
|
|
33,638
|
|
|
67,275
|
|
|
67,275
|
|
|
2,238,188
|
|
|||||
|
2015 senior debt
(5)
|
1,945,435
|
|
|
28,031
|
|
|
56,063
|
|
|
56,063
|
|
|
1,805,278
|
|
|||||
|
2017 junior debt
(6)
|
833,751
|
|
|
12,938
|
|
|
25,875
|
|
|
25,875
|
|
|
769,063
|
|
|||||
|
2007 junior debt
(7)
|
207,008
|
|
|
3,055
|
|
|
6,109
|
|
|
6,109
|
|
|
191,735
|
|
|||||
|
Pension obligations
(8)
|
13,677
|
|
|
700
|
|
|
1,731
|
|
|
2,582
|
|
|
8,664
|
|
|||||
|
Total contractual obligations
(9)
|
$
|
5,646,588
|
|
|
$
|
255,625
|
|
|
$
|
194,662
|
|
|
$
|
180,829
|
|
|
$
|
5,015,472
|
|
|
|
Financial instruments maturing during the fiscal year ended March 31,
|
||||||||||||||||||||||
|
|
2018
|
|
2019
|
|
2020
|
|
2021
|
|
2022
|
|
Thereafter
|
||||||||||||
|
Available-for-sale securities
|
$
|
342,500
|
|
|
$
|
10,024
|
|
|
$
|
147,435
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
Weighted-average yield rate
|
1.05
|
%
|
|
1.72
|
%
|
|
1.73
|
%
|
|
—
|
%
|
|
—
|
%
|
|
—
|
%
|
||||||
|
Item 9.
|
CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE
|
|
Item 12.
|
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS
|
|
|
|
Page No.
|
|
(1)
|
Financial Statements:
|
|
|
|
Report of Independent Registered Public Accounting Firm
|
F-1
|
|
|
Report of Independent Registered Public Accounting Firm on Internal Control Over Financial Reporting
|
F-2
|
|
|
Consolidated Balance Sheets as of March 31, 2017 and 2016
|
F-3
|
|
|
Consolidated Statements of Income for each of the three years in the period ended March 31, 2017
|
F-4
|
|
|
Consolidated Statements of Comprehensive Income for each of the three years in the period ended March 31, 2017
|
F-5
|
|
|
Consolidated Statements of Cash Flows for each of the three years in the period ended March 31, 2017
|
F-6
|
|
|
Consolidated Statements of Changes in Equity for each of the three years in the period ended March 31, 2017
|
F-8
|
|
|
Notes to Consolidated Financial Statements
|
F-10
|
|
(2)
|
Financial Statement Schedules
|
None
|
|
(3)
|
The Exhibits filed with this Form 10-K or incorporated herein by reference are set
forth in the Exhibit Index beginning on page 59 hereof, which Exhibit Index is incorporated herein by this reference.
|
|
|
|
MICROCHIP TECHNOLOGY INCORPORATED
|
|
|
(Registrant)
|
|
|
|
|
May 30, 2017
|
By:
/s/ Steve Sanghi
|
|
|
Steve Sanghi
|
|
|
Chief Executive Officer and Chairman of the Board
|
|
Name and Signature
|
|
|
Title
|
|
Date
|
|
|
|
|
|
|
|
|
/s/ Steve Sanghi
|
|
|
Chief Executive Officer and Chairman of the Board
|
|
May 30, 2017
|
|
Steve Sanghi
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
/s/ Matthew W. Chapman
|
|
|
Director
|
|
May 30, 2017
|
|
Matthew W. Chapman
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
/s/ L.B. Day
|
|
|
Director
|
|
May 30, 2017
|
|
L.B. Day
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
/s/ Esther L. Johnson
|
|
|
Director
|
|
May 30, 2017
|
|
Esther L. Johnson
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
/s/ Wade F. Meyercord
|
|
|
Director
|
|
May 30, 2017
|
|
Wade F. Meyercord
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
/s/ J. Eric Bjornholt
|
|
|
Vice President and Chief Financial Officer
|
|
May 30, 2017
|
|
J. Eric Bjornholt
|
|
|
(Principal Financial and Accounting Officer)
|
|
|
|
|
|
|
|
Incorporated by Reference
|
|
|
||||||
|
Exhibit Number
|
|
Exhibit Description
|
|
Form
|
|
File Number
|
|
Exhibit
|
|
Filing Date
|
|
Filed Herewith
|
|
2.1
|
|
Agreement and Plan of Merger dated as of May 22, 2014 by and among Microchip Technology (Barbados) II Incorporated and ISSC Technologies Corp.
|
|
10-K
|
|
000-21184
|
|
2.1
|
|
5/30/2014
|
|
|
|
2.2
|
|
Tender Agreement dated May 22, 2014 between Microchip Technology (Barbados) II Incorporated and Directors, Certain Officers and Certain Shareholders of ISSC Technologies Corp.
|
|
10-K
|
|
000-21184
|
|
2.2
|
|
5/30/2014
|
|
|
|
2.3
|
|
Guaranty Concerning Merger Agreement dated May 22, 2014 made by Microchip Technology Incorporated with respect to certain obligations of Microchip Technology (Barbados) II Incorporated
|
|
10-K
|
|
000-21184
|
|
2.3
|
|
5/30/2014
|
|
|
|
2.4
|
|
Guaranty Concerning Tender Agreement dated May 22, 2014 made by Microchip Technology Incorporated with respect to certain obligations of Microchip Technology (Barbados) II Incorporated
|
|
10-K
|
|
000-21184
|
|
2.4
|
|
5/30/2014
|
|
|
|
2.5
|
|
Agreement and Plan of Merger dated as of February 9, 2014 by and among Microchip Technology Incorporated, Orchid Acquisition Corporation and Supertex, Inc.
|
|
10-K
|
|
000-21184
|
|
2.5
|
|
5/30/2014
|
|
|
|
2.6
|
|
Agreement and Plan of Merger dated as of May 1, 2012 by and among Microchip Technology Incorporated, Microchip Technology Management Co. and Standard Microsystems Corporation, including Form of Voting Agreement
|
|
10-K
|
|
000-21184
|
|
2.2
|
|
5/30/2012
|
|
|
|
2.7
|
|
Agreement and Plan of Merger dated as of May 7, 2015, by and among, Microchip Technology Incorporated, Micrel, Incorporated, Mambo Acquisition Corp. and Mambo Acquisition LLC
|
|
8-K
|
|
000-21184
|
|
2.1
|
|
5/8/2015
|
|
|
|
2.8
|
|
Agreement and Plan of Merger, dated as of January 19, 2016, by and among Microchip Technology, Atmel Corporation, and Hero Acquisition Corporation
|
|
8-K
|
|
000-21184
|
|
2.1
|
|
1/19/2016
|
|
|
|
3.1
|
|
Restated Certificate of Incorporation of Registrant
|
|
10-Q
|
|
000-21184
|
|
3.1
|
|
11/12/2002
|
|
|
|
3.2
|
|
Amended and Restated By-Laws of Registrant, as amended through November 14, 2016
|
|
8-K
|
|
000-21184
|
|
3.1
|
|
11/17/2016
|
|
|
|
4.1
|
|
Indenture, dated as of December 7, 2007, by and between Wells Fargo Bank, National Association, as Trustee, and Microchip Technology Incorporated
|
|
8-K
|
|
000-21184
|
|
4.1
|
|
12/7/2007
|
|
|
|
4.2
|
|
Indenture dated as of February 11, 2015 between Microchip Technology Incorporated and Wells Fargo Bank, N.A.
|
|
8-K
|
|
000-21184
|
|
4.1
|
|
2/11/2015
|
|
|
|
4.3
|
|
Indenture dated as of February 15, 2017 between Microchip Technology Incorporated and Wells Fargo Bank, National Association
|
|
8-K
|
|
000-21184
|
|
4.1
|
|
2/15/2017
|
|
|
|
|
|
|
|
Incorporated by Reference
|
|
|
||||||
|
Exhibit Number
|
|
Exhibit Description
|
|
Form
|
|
File Number
|
|
Exhibit
|
|
Filing Date
|
|
Filed Herewith
|
|
4.4
|
|
Indenture dated as of February 15, 2017 between Microchip Technology Incorporated and Wells Fargo Bank, National Association
|
|
8-K
|
|
000-21184
|
|
4.3
|
|
2/15/2017
|
|
|
|
4.5
|
|
Registration Rights Agreement, dated as of December 7, 2007, by and between J.P. Morgan Securities Inc. and Microchip Technology Incorporated
|
|
8-K
|
|
000-21184
|
|
4.2
|
|
12/7/2007
|
|
|
|
10.1
|
|
Master Increasing Lender Supplement dated as of March 19, 2015, by and among Microchip Technology Incorporated and the Increasing Lenders thereto
|
|
10-K
|
|
000-21184
|
|
10.1
|
|
6/8/2015
|
|
|
|
10.2
|
|
Amendment No. 2, dated as of February 8, 2017, to Amended and Restated Credit Agreement, dated as of June 27, 2013, as amended and restated as of February 4, 2015
|
|
8-K
|
|
000-21184
|
|
10.1
|
|
2/8/2017
|
|
|
|
10.3
|
|
Amendment No. 1, dated December 4, 2015, to Amended and Restated Credit Agreement, dated as of June 27, 2013, as amended and restated as of February 4, 2015
|
|
8-K
|
|
000-21184
|
|
10.1
|
|
12/7/2015
|
|
|
|
10.4
|
|
Amendment and Restatement Agreement dated as of February 4, 2015, to the Credit Agreement, dated as of June 27, 2013, by and among Microchip Technology Incorporated, the lenders party thereto and JPMorgan Chase Bank, N.A., as Administrative Agent
|
|
8-K
|
|
000-21184
|
|
10.1
|
|
2/4/2015
|
|
|
|
10.5
|
|
Pledge and Security Agreement, dated as of February 8, 2017, by and among Microchip Technology Incorporated, the other grantors party thereto and JPMorgan Chase Bank, N.A., as Administrative Agent
|
|
8-K
|
|
000-21184
|
|
10.2
|
|
2/8/2017
|
|
|
|
10.6
|
|
Form of Indemnification Agreement between Registrant and its directors and certain of its officers
|
|
S-1
|
|
33-57960
|
|
10.1
|
|
2/5/1993
|
|
|
|
10.7
|
|
Microchip Technology Incorporated 2012 Inducement Award Plan
|
|
S-8
|
|
333-183074
|
|
4.8
|
|
8/3/2012
|
|
|
|
10.8
|
|
*2004 Equity Incentive Plan as amended and restated August 14, 2015
|
|
8-K
|
|
000-21184
|
|
10.1
|
|
8/18/2015
|
|
|
|
10.9
|
|
*Form of Notice of Grant of Restricted Stock Units (officer) for 2004 Equity Incentive Plan
|
|
S-8
|
|
333-192273
|
|
10.2
|
|
11/12/2013
|
|
|
|
10.10
|
|
Form of Notice of Grant of Restricted Stock Units (non-officer) for 2004 Equity Incentive Plan
|
|
S-8
|
|
333-192273
|
|
10.3
|
|
11/12/2013
|
|
|
|
10.11
|
|
*Form of Notice of Grant for 2004 Equity Incentive Plan (including Exhibit A Stock Option Agreement)
|
|
S-8
|
|
333-119939
|
|
4.5
|
|
10/25/2004
|
|
|
|
10.12
|
|
Form of Notice of Grant (Foreign) for 2004 Equity Incentive Plan (including Exhibit A Stock Option Agreement (Foreign))
|
|
10-K
|
|
000-21184
|
|
10.4
|
|
5/23/2005
|
|
|
|
10.13
|
|
*Form of Notice of Grant of Restricted Stock Units for 2004 Equity Incentive Plan (including Exhibit A Restricted Stock Units Agreement)
|
|
10-K
|
|
000-21184
|
|
10.6
|
|
5/31/2006
|
|
|
|
10.14
|
|
*Restricted Stock Units Agreement (Domestic) for 2004 Equity Incentive Plan
|
|
10-Q
|
|
000-21184
|
|
10.3
|
|
11/7/2007
|
|
|
|
|
|
|
|
Incorporated by Reference
|
|
|
||||||
|
Exhibit Number
|
|
Exhibit Description
|
|
Form
|
|
File Number
|
|
Exhibit
|
|
Filing Date
|
|
Filed Herewith
|
|
10.15
|
|
Restricted Stock Units Agreement (Foreign) for 2004 Equity Incentive Plan
|
|
10-Q
|
|
000-21184
|
|
10.4
|
|
11/7/2008
|
|
|
|
10.16
|
|
*Form of Global RSU Agreement for 2004 Equity Incentive Plan (including Notice of Grant of Restricted Stock Units)
|
|
8-K
|
|
000-21184
|
|
10.1
|
|
9/27/2010
|
|
|
|
10.17
|
|
*Microchip Technology Incorporated 2001 Employee Stock Purchase Plan as amended through March 1, 2012
|
|
10-Q
|
|
000-21184
|
|
10.1
|
|
2/6/2012
|
|
|
|
10.18
|
|
Microchip Technology Incorporated International Employee Stock Purchase Plan as amended through May 19, 2014, including Purchase Agreement
|
|
10-K
|
|
000-21184
|
|
10.17
|
|
5/30/2014
|
|
|
|
10.19
|
|
*Executive Management Incentive Compensation Plan as amended on May 16, 2016
|
|
8-K
|
|
000-21184
|
|
10.1
|
|
8/18/2016
|
|
|
|
10.20
|
|
*Discretionary Executive Management Incentive Compensation Plan
|
|
10-Q
|
|
000-21184
|
|
10.3
|
|
8/24/2006
|
|
|
|
10.21
|
|
Management Incentive Compensation Plan as amended by the Board of Directors on May 17, 2013
|
|
10-K
|
|
000-21184
|
|
10.21
|
|
5/30/2013
|
|
|
|
10.22
|
|
*Microchip Technology Incorporated Supplemental Retirement Plan
|
|
S-8
|
|
333-101696
|
|
4.1.1
|
|
12/6/2002
|
|
|
|
10.23
|
|
*Adoption Agreement to the Microchip Technology Incorporated Supplemental Retirement Plan dated January 1, 1997
|
|
S-8
|
|
333-101696
|
|
4.1.3
|
|
12/6/2002
|
|
|
|
10.24
|
|
*Amendment dated December 9, 1999 to the Adoption Agreement to the Microchip Technology Incorporated Supplemental Retirement Plan
|
|
S-8
|
|
333-101696
|
|
4.1.4
|
|
12/6/2002
|
|
|
|
10.25
|
|
*February 3, 2003 Amendment to the Adoption Agreement to the Microchip Technology Incorporated Supplemental Retirement Plan
|
|
10-K
|
|
000-21184
|
|
10.28
|
|
6/5/2003
|
|
|
|
10.26
|
|
*Amendments to Supplemental Retirement Plan
|
|
10-Q
|
|
000-21184
|
|
10.1
|
|
2/9/2006
|
|
|
|
10.27
|
|
*Amended and Restated Adoption Agreement to the Microchip Technology Incorporated Supplemental Retirement Plan dated October 8, 2008, as amended December 15, 2008
|
|
10-K
|
|
000-21184
|
|
10.28
|
|
5/24/2016
|
|
|
|
10.28
|
|
*Change of Control Severance Agreement
|
|
8-K
|
|
000-21184
|
|
10.1
|
|
12/18/2008
|
|
|
|
10.29
|
|
*Change of Control Severance Agreement
|
|
8-K
|
|
000-21184
|
|
10.2
|
|
12/18/2008
|
|
|
|
10.30
|
|
Development Agreement dated as of August 29, 1997 by and between Registrant and the City of Chandler, Arizona
|
|
10-Q
|
|
000-21184
|
|
10.1
|
|
2/13/1998
|
|
|
|
10.31
|
|
Addendum to Development Agreement by and between Registrant and the City of Tempe, Arizona, dated May 11, 2000
|
|
10-K
|
|
000-21184
|
|
10.14
|
|
5/15/2001
|
|
|
|
10.32
|
|
Development Agreement dated as of July 17, 1997 by and between Registrant and the City of Tempe, Arizona
|
|
10-Q
|
|
000-21184
|
|
10.2
|
|
2/13/1998
|
|
|
|
10.33
|
|
Amended Strategic Investment Program Contract dated as of June 8, 2009 between, Multnomah County, Oregon, City of Gresham, Oregon and Microchip Technology Incorporated
|
|
8-K
|
|
000-21184
|
|
10.1
|
|
6/11/2009
|
|
|
|
|
|
|
|
Incorporated by Reference
|
|
|
||||||
|
Exhibit Number
|
|
Exhibit Description
|
|
Form
|
|
File Number
|
|
Exhibit
|
|
Filing Date
|
|
Filed Herewith
|
|
21.1
|
|
Subsidiaries of Registrant
|
|
|
|
|
|
|
|
|
|
X
|
|
23.1
|
|
Consent of Independent Registered Public Accounting Firm
|
|
|
|
|
|
|
|
|
|
X
|
|
24.1
|
|
Power of Attorney included on Page 58 of this Form 10-K
|
|
|
|
|
|
|
|
|
|
X
|
|
31.1
|
|
Certification of Chief Executive Officer Pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, as amended (the Exchange Act)
|
|
|
|
|
|
|
|
|
|
X
|
|
31.2
|
|
Certification of Chief Financial Officer Pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, as amended (the Exchange Act)
|
|
|
|
|
|
|
|
|
|
X
|
|
32
|
|
Certifications Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
|
|
|
|
|
|
|
|
|
X
|
|
|
|
*Compensation plans or arrangements in which directors or executive officers are eligible to participate.
|
|
|
|
|
|
|
|
|
|
|
|
|
Page Number
|
|
|
|
|
Report of Independent Registered Public Accounting Firm
|
F-1
|
|
|
|
|
Report of Independent Registered Public Accounting Firm on Internal Control Over Financial Reporting
|
F-2
|
|
|
|
|
Consolidated Balance Sheets as of March 31, 2017 and 2016
|
F-3
|
|
|
|
|
Consolidated Statements of Income for each of the three years in the period ended March 31, 2017
|
F-4
|
|
|
|
|
Consolidated Statements of Comprehensive Income for each of the three years in the period ended March 31, 2017
|
F-5
|
|
|
|
|
Consolidated Statements of Cash Flows for each of the three years in the period ended March 31, 2017
|
F-6
|
|
|
|
|
Consolidated Statements of Changes in Equity for each of the three years in the period ended March 31, 2017
|
F-8
|
|
|
|
|
Notes to Consolidated Financial Statements
|
F-10
|
|
Item1.
|
Financial Statements
|
|
ASSETS
|
|||||||
|
|
March 31,
|
||||||
|
|
2017
|
|
2016
|
||||
|
Cash and cash equivalents
|
$
|
908,684
|
|
|
$
|
2,092,751
|
|
|
Short-term investments
|
394,088
|
|
|
353,284
|
|
||
|
Accounts receivable, net
|
478,373
|
|
|
290,183
|
|
||
|
Inventories
|
417,202
|
|
|
306,815
|
|
||
|
Prepaid expenses
|
41,354
|
|
|
41,992
|
|
||
|
Assets held for sale
|
6,459
|
|
|
—
|
|
||
|
Other current assets
|
58,880
|
|
|
11,688
|
|
||
|
Total current assets
|
2,305,040
|
|
|
3,096,713
|
|
||
|
Property, plant and equipment, net
|
683,338
|
|
|
609,396
|
|
||
|
Long-term investments
|
107,457
|
|
|
118,549
|
|
||
|
Goodwill
|
2,299,009
|
|
|
1,012,652
|
|
||
|
Intangible assets, net
|
2,148,092
|
|
|
606,349
|
|
||
|
Long-term deferred tax assets
|
68,870
|
|
|
14,831
|
|
||
|
Other assets
|
75,075
|
|
|
79,393
|
|
||
|
Total assets
|
$
|
7,686,881
|
|
|
$
|
5,537,883
|
|
|
LIABILITIES AND STOCKHOLDERS' EQUITY
|
|||||||
|
Accounts payable
|
$
|
149,233
|
|
|
$
|
79,312
|
|
|
Accrued liabilities
|
212,450
|
|
|
119,265
|
|
||
|
Deferred income on shipments to distributors
|
292,815
|
|
|
183,432
|
|
||
|
Current portion of long-term debt
|
49,952
|
|
|
—
|
|
||
|
Total current liabilities
|
704,450
|
|
|
382,009
|
|
||
|
Long-term debt
|
2,900,524
|
|
|
2,453,405
|
|
||
|
Long-term income tax payable
|
184,945
|
|
|
111,061
|
|
||
|
Long-term deferred tax liability
|
409,045
|
|
|
399,218
|
|
||
|
Other long-term liabilities
|
217,206
|
|
|
41,271
|
|
||
|
Stockholders' equity:
|
|
|
|
||||
|
Preferred stock, $0.001 par value; authorized 5,000,000 shares; no shares issued or outstanding
|
—
|
|
|
—
|
|
||
|
Common stock, $0.001 par value; authorized 450,000,000 shares; 249,463,733 shares issued and 229,093,658 shares outstanding at March 31, 2017; 227,416,789 shares issued and 204,081,727 shares outstanding at March 31, 2016
|
229
|
|
|
204
|
|
||
|
Additional paid-in capital
|
2,537,344
|
|
|
1,391,553
|
|
||
|
Common stock held in treasury: 20,370,075 shares at March 31, 2017; 23,335,062 shares at March 31, 2016
|
(731,884
|
)
|
|
(820,066
|
)
|
||
|
Accumulated other comprehensive loss
|
(14,378
|
)
|
|
(3,357
|
)
|
||
|
Retained earnings
|
1,479,400
|
|
|
1,582,585
|
|
||
|
Total stockholders' equity
|
3,270,711
|
|
|
2,150,919
|
|
||
|
Total liabilities and stockholders' equity
|
$
|
7,686,881
|
|
|
$
|
5,537,883
|
|
|
See accompanying notes to consolidated financial statements
|
|||||||
|
|
Year ended March 31,
|
||||||||||
|
|
2017
|
|
2016
|
|
2015
|
||||||
|
Net sales
|
$
|
3,407,807
|
|
|
$
|
2,173,334
|
|
|
$
|
2,147,036
|
|
|
Cost of sales (1)
|
1,650,611
|
|
|
967,870
|
|
|
917,472
|
|
|||
|
Gross profit
|
1,757,196
|
|
|
1,205,464
|
|
|
1,229,564
|
|
|||
|
|
|
|
|
|
|
|
|
||||
|
Research and development (1)
|
545,293
|
|
|
372,596
|
|
|
349,543
|
|
|||
|
Selling, general and administrative (1)
|
499,811
|
|
|
301,670
|
|
|
274,815
|
|
|||
|
Amortization of acquired intangible assets
|
337,667
|
|
|
174,896
|
|
|
176,746
|
|
|||
|
Special charges and other, net
|
98,608
|
|
|
3,957
|
|
|
2,840
|
|
|||
|
Operating expenses
|
1,481,379
|
|
|
853,119
|
|
|
803,944
|
|
|||
|
|
|
|
|
|
|
||||||
|
Operating income
|
275,817
|
|
|
352,345
|
|
|
425,620
|
|
|||
|
Losses on equity method investments
|
(222
|
)
|
|
(345
|
)
|
|
(317
|
)
|
|||
|
Other income (expense):
|
|
|
|
|
|
||||||
|
Interest income
|
3,079
|
|
|
24,447
|
|
|
19,527
|
|
|||
|
Interest expense
|
(146,346
|
)
|
|
(104,018
|
)
|
|
(62,034
|
)
|
|||
|
Loss on settlement of convertible debt
|
(43,879
|
)
|
|
—
|
|
|
(50,631
|
)
|
|||
|
Other income, net
|
1,338
|
|
|
8,864
|
|
|
13,742
|
|
|||
|
Income before income taxes
|
89,787
|
|
|
281,293
|
|
|
345,907
|
|
|||
|
Income tax benefit
|
(80,805
|
)
|
|
(42,632
|
)
|
|
(19,418
|
)
|
|||
|
Net income from continuing operations
|
170,592
|
|
|
323,925
|
|
|
365,325
|
|
|||
|
Discontinued operations:
|
|
|
|
|
|
||||||
|
Loss from discontinued operations
|
(7,514
|
)
|
|
—
|
|
|
—
|
|
|||
|
Income tax benefit
|
(1,561
|
)
|
|
—
|
|
|
—
|
|
|||
|
Net loss from discontinued operations
|
(5,953
|
)
|
|
—
|
|
|
—
|
|
|||
|
|
|
|
|
|
|
||||||
|
Net Income
|
164,639
|
|
|
323,925
|
|
|
365,325
|
|
|||
|
Less: Net loss attributable to noncontrolling interests
|
—
|
|
|
207
|
|
|
3,684
|
|
|||
|
Net income attributable to Microchip Technology
|
$
|
164,639
|
|
|
$
|
324,132
|
|
|
$
|
369,009
|
|
|
|
|
|
|
|
|
||||||
|
Basic net income per common share attributable to Microchip Technology stockholders
|
|
|
|
|
|
||||||
|
Net income from continuing operations
|
$
|
0.79
|
|
|
$
|
1.59
|
|
|
$
|
1.84
|
|
|
Net loss from discontinued operations
|
$
|
(0.03
|
)
|
|
$
|
—
|
|
|
$
|
—
|
|
|
Net income attributable to Microchip Technology
|
$
|
0.76
|
|
|
$
|
1.59
|
|
|
$
|
1.84
|
|
|
Diluted net income per common share attributable to Microchip Technology stockholders
|
|
|
|
|
|
||||||
|
Net income from continuing operations
|
$
|
0.73
|
|
|
$
|
1.49
|
|
|
$
|
1.65
|
|
|
Net loss from discontinued operations
|
$
|
(0.02
|
)
|
|
$
|
—
|
|
|
$
|
—
|
|
|
Net income attributable to Microchip Technology
|
$
|
0.71
|
|
|
$
|
1.49
|
|
|
$
|
1.65
|
|
|
Dividends declared per common share
|
$
|
1.441
|
|
|
$
|
1.433
|
|
|
$
|
1.425
|
|
|
Basic common shares outstanding
|
217,196
|
|
|
203,384
|
|
|
200,937
|
|
|||
|
Diluted common shares outstanding
|
234,806
|
|
|
217,388
|
|
|
223,561
|
|
|||
|
|
|
|
|
|
|
||||||
|
(1) Includes share-based compensation expense as follows:
|
|
|
|
|
|
||||||
|
Cost of sales
|
$
|
18,713
|
|
|
$
|
8,252
|
|
|
$
|
9,010
|
|
|
Research and development
|
46,801
|
|
|
32,022
|
|
|
28,164
|
|
|||
|
Selling, general and administrative
|
62,641
|
|
|
31,146
|
|
|
21,422
|
|
|||
|
|
Year Ended March 31,
|
||||||||||
|
|
2017
|
|
2016
|
|
2015
|
||||||
|
Net income
|
$
|
164,639
|
|
|
$
|
323,925
|
|
|
$
|
365,325
|
|
|
Less: Net loss attributable to noncontrolling interests
|
—
|
|
|
207
|
|
|
3,684
|
|
|||
|
Net income attributable to Microchip Technology
|
164,639
|
|
|
324,132
|
|
|
369,009
|
|
|||
|
|
|
|
|
|
|
||||||
|
Components of other comprehensive (loss) income:
|
|
|
|
|
|
||||||
|
Available-for sale securities:
|
|
|
|
|
|
||||||
|
Unrealized holding (losses) gains, net of tax effect
|
(1,558
|
)
|
|
(3,241
|
)
|
|
33,759
|
|
|||
|
Reclassification of realized transactions, net of tax effect
|
1,522
|
|
|
(10,948
|
)
|
|
(18,694
|
)
|
|||
|
Actuarial (losses) gains related to defined benefit pension plans, net of tax benefit (provision) of $2,172, ($18), and $76
|
(5,307
|
)
|
|
31
|
|
|
(127
|
)
|
|||
|
Change in net foreign currency translation adjustment
|
(5,678
|
)
|
|
—
|
|
|
(5,188
|
)
|
|||
|
Other comprehensive (loss) income, net of taxes
|
(11,021
|
)
|
|
(14,158
|
)
|
|
9,750
|
|
|||
|
Less: Other comprehensive loss attributable to noncontrolling interests
|
—
|
|
|
—
|
|
|
866
|
|
|||
|
Other comprehensive (loss) income attributable to Microchip Technology
|
(11,021
|
)
|
|
(14,158
|
)
|
|
10,616
|
|
|||
|
|
|
|
|
|
|
||||||
|
Comprehensive income
|
153,618
|
|
|
309,767
|
|
|
375,075
|
|
|||
|
Less: Comprehensive loss attributable to noncontrolling interests
|
—
|
|
|
207
|
|
|
4,550
|
|
|||
|
Comprehensive income attributable to Microchip Technology
|
$
|
153,618
|
|
|
$
|
309,974
|
|
|
$
|
379,625
|
|
|
|
Year ended March 31,
|
||||||||||
|
|
2017
|
|
2016
|
|
2015
|
||||||
|
Cash flows from operating activities:
|
|
|
|
|
|
||||||
|
Net income
|
$
|
164,639
|
|
|
$
|
323,925
|
|
|
$
|
365,325
|
|
|
Adjustments to reconcile net income to net cash provided by operating activities:
|
|
|
|
|
|
||||||
|
Depreciation and amortization
|
469,208
|
|
|
283,171
|
|
|
278,298
|
|
|||
|
Deferred income taxes
|
(126,888
|
)
|
|
(60,425
|
)
|
|
(32,811
|
)
|
|||
|
Share-based compensation expense related to equity incentive plans
|
128,155
|
|
|
71,420
|
|
|
58,596
|
|
|||
|
Excess tax benefit from share-based compensation
|
—
|
|
|
(758
|
)
|
|
(1,216
|
)
|
|||
|
Loss on settlement of convertible debt
|
43,879
|
|
|
—
|
|
|
50,631
|
|
|||
|
Amortization of debt discount on convertible debt
|
56,075
|
|
|
48,022
|
|
|
14,791
|
|
|||
|
Amortization of debt issuance costs
|
4,524
|
|
|
3,968
|
|
|
2,463
|
|
|||
|
Losses on equity method investments
|
222
|
|
|
345
|
|
|
317
|
|
|||
|
Gains on sale of assets
|
(78
|
)
|
|
(960
|
)
|
|
—
|
|
|||
|
Loss on write-down of fixed assets
|
2,571
|
|
|
—
|
|
|
362
|
|
|||
|
Impairment of intangible assets
|
11,904
|
|
|
629
|
|
|
1,881
|
|
|||
|
Realized losses (gain) on available-for-sale investments
|
89
|
|
|
(13,727
|
)
|
|
(18,469
|
)
|
|||
|
Realized gain on equity method investment
|
(468
|
)
|
|
(2,225
|
)
|
|
—
|
|
|||
|
Impairment of available-for-sale investment
|
1,433
|
|
|
3,995
|
|
|
—
|
|
|||
|
Amortization of premium on available-for-sale investments
|
18
|
|
|
9,044
|
|
|
9,949
|
|
|||
|
Changes in operating assets and liabilities, excluding impact of acquisitions:
|
|
|
|
|
|
||||||
|
Increase in accounts receivable
|
(46,831
|
)
|
|
(2,150
|
)
|
|
(15,893
|
)
|
|||
|
Decrease in inventories
|
223,711
|
|
|
48,245
|
|
|
25,517
|
|
|||
|
Increase in deferred income on shipments to distributors
|
109,383
|
|
|
16,962
|
|
|
18,330
|
|
|||
|
Decrease in accounts payable and accrued liabilities
|
(16,070
|
)
|
|
(20,836
|
)
|
|
(33,992
|
)
|
|||
|
Change in other assets and liabilities
|
24,628
|
|
|
35,838
|
|
|
(2,897
|
)
|
|||
|
Operating cash flows related to discontinued operations
|
9,348
|
|
|
—
|
|
|
—
|
|
|||
|
Net cash provided by operating activities
|
1,059,452
|
|
|
744,483
|
|
|
721,182
|
|
|||
|
Cash flows from investing activities:
|
|
|
|
|
|
|
|
||||
|
Purchases of available-for-sale investments
|
(500,309
|
)
|
|
(1,573,867
|
)
|
|
(959,318
|
)
|
|||
|
Sales and maturities of available-for-sale investments
|
470,565
|
|
|
2,824,231
|
|
|
1,097,065
|
|
|||
|
Sale of equity method investment
|
1,746
|
|
|
2,667
|
|
|
—
|
|
|||
|
Acquisition of Atmel, net of cash acquired
|
(2,747,516
|
)
|
|
—
|
|
|
—
|
|
|||
|
Acquisition of Micrel, net of cash acquired
|
—
|
|
|
(343,928
|
)
|
|
—
|
|
|||
|
Acquisition of ISSC, net of cash acquired
|
—
|
|
|
—
|
|
|
(252,469
|
)
|
|||
|
Purchase of additional controlling interest in ISSC
|
—
|
|
|
(18,051
|
)
|
|
(32,095
|
)
|
|||
|
Acquisition of Supertex, net of cash acquired
|
—
|
|
|
—
|
|
|
(375,365
|
)
|
|||
|
Investments in other assets
|
(10,218
|
)
|
|
(7,056
|
)
|
|
(6,663
|
)
|
|||
|
Proceeds from sale of assets
|
23,069
|
|
|
14,296
|
|
|
—
|
|
|||
|
Capital expenditures
|
(75,310
|
)
|
|
(97,895
|
)
|
|
(149,472
|
)
|
|||
|
Net cash (used in) provided by investing activities
|
(2,837,973
|
)
|
|
800,397
|
|
|
(678,317
|
)
|
|||
|
Cash flows from financing activities:
|
|
|
|
|
|
|
|
||||
|
Payments on settlement of convertible debt
|
(436,205
|
)
|
|
—
|
|
|
(1,134,621
|
)
|
|||
|
Proceeds from issuance of 2017 senior debt
|
2,070,000
|
|
|
—
|
|
|
—
|
|
|||
|
Proceeds from issuance of 2017 junior debt
|
575,000
|
|
|
—
|
|
|
—
|
|
|||
|
Proceeds from issuance of 2015 senior debt
|
—
|
|
|
—
|
|
|
1,725,000
|
|
|||
|
Repayments of revolving loan under credit facility
|
(2,781,000
|
)
|
|
(1,614,452
|
)
|
|
(1,697,642
|
)
|
|||
|
Proceeds from borrowings on revolving loan under credit facility
|
1,537,000
|
|
|
2,204,500
|
|
|
1,859,594
|
|
|||
|
Repayments of long-term borrowings
|
—
|
|
|
—
|
|
|
(350,000
|
)
|
|||
|
Deferred financing costs
|
(36,930
|
)
|
|
(2,156
|
)
|
|
(32,846
|
)
|
|||
|
Payment of cash dividends
|
(315,429
|
)
|
|
(291,087
|
)
|
|
(286,478
|
)
|
|||
|
Repurchase of common stock
|
—
|
|
|
(363,829
|
)
|
|
—
|
|
|||
|
Proceeds from sale of common stock
|
42,210
|
|
|
28,718
|
|
|
34,433
|
|
|||
|
Tax payments related to shares withheld for vested restricted stock units
|
(58,402
|
)
|
|
(21,720
|
)
|
|
(19,504
|
)
|
|||
|
Capital lease payments
|
(783
|
)
|
|
(676
|
)
|
|
(604
|
)
|
|||
|
|
Year ended March 31,
|
||||||||||
|
|
2017
|
|
2016
|
|
2015
|
||||||
|
Excess tax benefit from share-based compensation
|
—
|
|
|
758
|
|
|
1,216
|
|
|||
|
Net cash provided by (used in) financing activities
|
595,461
|
|
|
(59,944
|
)
|
|
98,548
|
|
|||
|
Effect of foreign exchange rate changes on cash and cash equivalents
|
(1,007
|
)
|
|
—
|
|
|
(201
|
)
|
|||
|
Net (decrease) increase in cash and cash equivalents
|
(1,184,067
|
)
|
|
1,484,936
|
|
|
141,212
|
|
|||
|
Cash and cash equivalents at beginning of period
|
2,092,751
|
|
|
607,815
|
|
|
466,603
|
|
|||
|
Cash and cash equivalents at end of period
|
$
|
908,684
|
|
|
$
|
2,092,751
|
|
|
$
|
607,815
|
|
|
|
|
Common Stock and Additional Paid-in-Capital
|
|
Common Stock Held
in Treasury
|
|
Accumulated Other Comprehensive Income
|
|
Retained
Earnings
|
|
Net Microchip Technology Stockholders' Equity
|
|
Noncontrolling Interests
|
|
Total Equity
|
||||||||||||||||||||
|
|
|
Shares
|
|
Amount
|
|
Shares
|
|
Amount
|
|
|||||||||||||||||||||||||
|
Balance at March 31, 2014
|
|
218,790
|
|
|
$
|
1,244,783
|
|
|
18,787
|
|
|
$
|
(577,382
|
)
|
|
$
|
1,051
|
|
|
$
|
1,467,009
|
|
|
$
|
2,135,461
|
|
|
$
|
—
|
|
|
$
|
2,135,461
|
|
|
Acquisition of controlling interest in ISSC
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
52,467
|
|
|
52,467
|
|
|||||||
|
Net income (loss)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
369,009
|
|
|
369,009
|
|
|
(3,684
|
)
|
|
365,325
|
|
|||||||
|
Other comprehensive income
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
10,616
|
|
|
—
|
|
|
10,616
|
|
|
(866
|
)
|
|
9,750
|
|
|||||||
|
Other
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
240
|
|
|
240
|
|
|||||||
|
Purchase of additional shares from noncontrolling interest
|
|
—
|
|
|
345
|
|
|
—
|
|
|
—
|
|
|
(591
|
)
|
|
—
|
|
|
(246
|
)
|
|
(31,849
|
)
|
|
(32,095
|
)
|
|||||||
|
Proceeds from sales of common stock through employee equity incentive plans
|
|
2,503
|
|
|
34,369
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
34,369
|
|
|
64
|
|
|
34,433
|
|
|||||||
|
Restricted stock unit and stock appreciation right withholdings
|
|
(426
|
)
|
|
(19,504
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(19,504
|
)
|
|
—
|
|
|
(19,504
|
)
|
|||||||
|
Treasury stock used for new issuances
|
|
(2,077
|
)
|
|
(61,703
|
)
|
|
(2,077
|
)
|
|
61,703
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||||
|
Tax benefit from equity incentive plans
|
|
—
|
|
|
1,220
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
1,220
|
|
|
—
|
|
|
1,220
|
|
|||||||
|
Share-based compensation
|
|
—
|
|
|
56,687
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
56,687
|
|
|
—
|
|
|
56,687
|
|
|||||||
|
Non-cash consideration, exchange of employee stock awards - Supertex acquisition
|
|
—
|
|
|
1,622
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
1,622
|
|
|
—
|
|
|
1,622
|
|
|||||||
|
Settlement of convertible debt
|
|
—
|
|
|
(606,926
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(606,926
|
)
|
|
—
|
|
|
(606,926
|
)
|
|||||||
|
Convertible Debt - issuance of 2015 senior debt
|
|
—
|
|
|
348,824
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
348,824
|
|
|
—
|
|
|
348,824
|
|
|||||||
|
Cash dividend
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(286,478
|
)
|
|
(286,478
|
)
|
|
—
|
|
|
(286,478
|
)
|
|||||||
|
Balance at March 31, 2015
|
|
218,790
|
|
|
999,717
|
|
|
16,710
|
|
|
(515,679
|
)
|
|
11,076
|
|
|
1,549,540
|
|
|
2,044,654
|
|
|
16,372
|
|
|
2,061,026
|
|
|||||||
|
Net income (loss)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
324,132
|
|
|
324,132
|
|
|
(207
|
)
|
|
323,925
|
|
|||||||
|
Other comprehensive loss
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(14,158
|
)
|
|
—
|
|
|
(14,158
|
)
|
|
—
|
|
|
(14,158
|
)
|
|||||||
|
Purchase of additional shares from noncontrolling interest
|
|
—
|
|
|
(1,611
|
)
|
|
—
|
|
|
—
|
|
|
(275
|
)
|
|
—
|
|
|
(1,886
|
)
|
|
(16,165
|
)
|
|
(18,051
|
)
|
|||||||
|
Issuance of common stock - Micrel acquisition
|
|
8,627
|
|
|
369,054
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
369,054
|
|
|
—
|
|
|
369,054
|
|
|||||||
|
Non-cash consideration, exchange of employee stock awards - Micrel acquisition
|
|
—
|
|
|
4,052
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
4,052
|
|
|
—
|
|
|
4,052
|
|
|||||||
|
Purchase of treasury stock
|
|
—
|
|
|
—
|
|
|
8,627
|
|
|
(363,829
|
)
|
|
—
|
|
|
—
|
|
|
(363,829
|
)
|
|
—
|
|
|
(363,829
|
)
|
|||||||
|
Proceeds from sales of common stock through employee equity incentive plans
|
|
2,491
|
|
|
28,718
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
28,718
|
|
|
—
|
|
|
28,718
|
|
|||||||
|
Restricted stock unit and stock appreciation right withholdings
|
|
(489
|
)
|
|
(21,720
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(21,720
|
)
|
|
—
|
|
|
(21,720
|
)
|
|||||||
|
Treasury stock used for new issuances
|
|
(2,002
|
)
|
|
(59,442
|
)
|
|
(2,002
|
)
|
|
59,442
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||||
|
Tax benefit from equity incentive plans
|
|
—
|
|
|
(567
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(567
|
)
|
|
—
|
|
|
(567
|
)
|
|||||||
|
|
|
Common Stock and Additional Paid-in-Capital
|
|
Common Stock Held
in Treasury
|
|
Accumulated Other Comprehensive Income
|
|
Retained
Earnings
|
|
Net Microchip Technology Stockholders' Equity
|
|
Noncontrolling Interests
|
|
Total Equity
|
||||||||||||||||||||
|
|
|
Shares
|
|
Amount
|
|
Shares
|
|
Amount
|
|
|||||||||||||||||||||||||
|
Share-based compensation
|
|
—
|
|
|
73,556
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
73,556
|
|
|
—
|
|
|
73,556
|
|
|||||||
|
Cash dividend
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(291,087
|
)
|
|
(291,087
|
)
|
|
—
|
|
|
(291,087
|
)
|
|||||||
|
Balance at March 31, 2016
|
|
227,417
|
|
|
1,391,757
|
|
|
23,335
|
|
|
(820,066
|
)
|
|
(3,357
|
)
|
|
1,582,585
|
|
|
2,150,919
|
|
|
—
|
|
|
2,150,919
|
|
|||||||
|
Net income
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
164,639
|
|
|
164,639
|
|
|
—
|
|
|
164,639
|
|
|||||||
|
Other comprehensive loss
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(11,021
|
)
|
|
—
|
|
|
(11,021
|
)
|
|
—
|
|
|
(11,021
|
)
|
|||||||
|
Issuance of common stock - Atmel acquisition
|
|
10,050
|
|
|
486,182
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
486,182
|
|
|
—
|
|
|
486,182
|
|
|||||||
|
Non-cash consideration, exchange of employee stock awards - Atmel acquisition
|
|
—
|
|
|
7,470
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
7,470
|
|
|
—
|
|
|
7,470
|
|
|||||||
|
Proceeds from sales of common stock through employee equity incentive plans
|
|
3,986
|
|
|
42,210
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
42,210
|
|
|
—
|
|
|
42,210
|
|
|||||||
|
Restricted stock unit and stock appreciation right withholdings
|
|
(1,021
|
)
|
|
(58,402
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(58,402
|
)
|
|
—
|
|
|
(58,402
|
)
|
|||||||
|
Adoption of ASU 2016-09, cumulative adjustment
|
|
—
|
|
|
1,967
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
47,605
|
|
|
49,572
|
|
|
—
|
|
|
49,572
|
|
|||||||
|
Treasury stock used for new issuances
|
|
(2,965
|
)
|
|
(88,182
|
)
|
|
(2,965
|
)
|
|
88,182
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||||
|
Share-based compensation
|
|
—
|
|
|
127,308
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
127,308
|
|
|
—
|
|
|
127,308
|
|
|||||||
|
Shares issued to settle convertible debt
|
|
11,997
|
|
|
862,651
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
862,651
|
|
|
—
|
|
|
862,651
|
|
|||||||
|
Settlement of convertible debt
|
|
—
|
|
|
(850,709
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(850,709
|
)
|
|
—
|
|
|
(850,709
|
)
|
|||||||
|
Convertible Debt - issuance of 2017 senior and junior debt
|
|
—
|
|
|
615,321
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
615,321
|
|
|
—
|
|
|
615,321
|
|
|||||||
|
Cash dividend
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(315,429
|
)
|
|
(315,429
|
)
|
|
—
|
|
|
(315,429
|
)
|
|||||||
|
Balance at March 31, 2017
|
|
249,464
|
|
|
$
|
2,537,573
|
|
|
20,370
|
|
|
$
|
(731,884
|
)
|
|
$
|
(14,378
|
)
|
|
$
|
1,479,400
|
|
|
$
|
3,270,711
|
|
|
$
|
—
|
|
|
$
|
3,270,711
|
|
|
See accompanying notes to consolidated financial statements
|
||||||||||||||||||||||||||||||||||
|
|
As of March 31, 2016
|
||||||||||
|
|
As Reported
|
|
Adjustments
|
|
As Adjusted
|
||||||
|
Other assets
|
$
|
109,025
|
|
|
$
|
(29,632
|
)
|
|
$
|
79,393
|
|
|
Total assets
|
$
|
5,567,515
|
|
|
$
|
(29,632
|
)
|
|
$
|
5,537,883
|
|
|
|
|
|
|
|
|
||||||
|
Long-term debt
|
$
|
2,483,037
|
|
|
$
|
(29,632
|
)
|
|
$
|
2,453,405
|
|
|
Total liabilities and stockholder's equity
|
$
|
5,567,515
|
|
|
$
|
(29,632
|
)
|
|
$
|
5,537,883
|
|
|
Assets acquired
|
As of June 30, 2016
|
|
Adjustments
|
|
March 31, 2017
|
||||||
|
Cash and cash equivalents
|
$
|
230,266
|
|
|
$
|
—
|
|
|
$
|
230,266
|
|
|
Accounts receivable
|
135,427
|
|
|
5,932
|
|
|
141,359
|
|
|||
|
Inventories
|
333,208
|
|
|
1,955
|
|
|
335,163
|
|
|||
|
Prepaid expenses and other current assets
|
28,360
|
|
|
—
|
|
|
28,360
|
|
|||
|
Assets held for sale
|
24,394
|
|
|
7,612
|
|
|
32,006
|
|
|||
|
Property, plant and equipment
|
129,587
|
|
|
297
|
|
|
129,884
|
|
|||
|
Goodwill
|
1,378,317
|
|
|
(91,946
|
)
|
|
1,286,371
|
|
|||
|
Purchased intangible assets
|
1,880,245
|
|
|
8,147
|
|
|
1,888,392
|
|
|||
|
Long-term deferred tax assets
|
49,466
|
|
|
(2,766
|
)
|
|
46,700
|
|
|||
|
Other assets
|
5,948
|
|
|
1,587
|
|
|
7,535
|
|
|||
|
Total assets acquired
|
4,195,218
|
|
|
(69,182
|
)
|
|
4,126,036
|
|
|||
|
|
|
|
|
|
|
||||||
|
Liabilities assumed
|
|
|
|
|
|
||||||
|
Accounts payable
|
(55,686
|
)
|
|
—
|
|
|
(55,686
|
)
|
|||
|
Other current liabilities
|
(119,152
|
)
|
|
(1,803
|
)
|
|
(120,955
|
)
|
|||
|
Long-term line of credit
|
(192,000
|
)
|
|
—
|
|
|
(192,000
|
)
|
|||
|
Deferred tax liabilities
|
(74,334
|
)
|
|
46,782
|
|
|
(27,552
|
)
|
|||
|
Long-term income tax payable
|
(174,380
|
)
|
|
59,203
|
|
|
(115,177
|
)
|
|||
|
Other long-term liabilities
|
(106,688
|
)
|
|
(35,000
|
)
|
|
(141,688
|
)
|
|||
|
Total liabilities assumed
|
(722,240
|
)
|
|
69,182
|
|
|
(653,058
|
)
|
|||
|
Purchase price allocated
|
$
|
3,472,978
|
|
|
$
|
—
|
|
|
$
|
3,472,978
|
|
|
Purchased Intangible Assets
|
Weighted Average
|
|
|
||
|
|
Useful Life
|
|
April 4, 2016
|
||
|
|
(in years)
|
|
(in thousands)
|
||
|
Core and developed technology
|
11
|
|
$
|
1,074,987
|
|
|
In-process research and development
|
—
|
|
140,700
|
|
|
|
Customer-related
|
6
|
|
630,600
|
|
|
|
Backlog
|
1
|
|
40,300
|
|
|
|
Other
|
5
|
|
1,805
|
|
|
|
Total purchased intangible assets
|
|
|
$
|
1,888,392
|
|
|
|
Year Ended Ended
|
||||||
|
|
March 31,
|
||||||
|
|
2017
|
|
2016
|
||||
|
Net sales
|
$
|
3,494
|
|
|
$
|
3,159
|
|
|
Net income (loss) from continuing operations
|
$
|
337
|
|
|
$
|
(384
|
)
|
|
Basic net income (loss) per common share
|
$
|
1.55
|
|
|
$
|
(1.80
|
)
|
|
Diluted net income (loss) per common share
|
$
|
1.43
|
|
|
$
|
(1.80
|
)
|
|
Assets acquired
|
|
||
|
Cash and cash equivalents
|
$
|
99,196
|
|
|
Accounts receivable, net
|
14,096
|
|
|
|
Inventories
|
73,468
|
|
|
|
Prepaid expenses and other current assets
|
10,652
|
|
|
|
Property, plant and equipment, net
|
38,491
|
|
|
|
Goodwill
|
440,978
|
|
|
|
Purchased intangible assets
|
273,500
|
|
|
|
Other assets
|
4,268
|
|
|
|
Total assets acquired
|
954,649
|
|
|
|
|
|
||
|
Liabilities assumed
|
|
||
|
Accounts payable
|
(11,068
|
)
|
|
|
Other current liabilities
|
(31,552
|
)
|
|
|
Deferred tax liabilities
|
(88,035
|
)
|
|
|
Long-term income tax payable
|
(7,637
|
)
|
|
|
Other long-term liabilities
|
(127
|
)
|
|
|
Total liabilities assumed
|
(138,419
|
)
|
|
|
Purchase price allocated
|
$
|
816,230
|
|
|
Purchased Intangible Assets
|
Weighted Average
|
|
|
||
|
|
Useful Life
|
|
August 3, 2015
|
||
|
|
(in years)
|
|
(in thousands)
|
||
|
Core and developed technology
|
10
|
|
$
|
175,800
|
|
|
In-process research and development
|
—
|
|
21,000
|
|
|
|
Customer-related
|
5
|
|
71,100
|
|
|
|
Backlog
|
1
|
|
5,600
|
|
|
|
Total purchased intangible assets
|
|
|
$
|
273,500
|
|
|
Assets acquired
|
|
||
|
Cash and cash equivalents
|
$
|
15,120
|
|
|
Short-term investments
|
27,063
|
|
|
|
Accounts receivable, net
|
8,792
|
|
|
|
Inventories
|
16,542
|
|
|
|
Prepaid expenses and other current assets
|
2,501
|
|
|
|
Property, plant and equipment, net
|
2,637
|
|
|
|
Goodwill
|
154,788
|
|
|
|
Purchased intangible assets
(1)
|
147,800
|
|
|
|
Other assets
|
1,370
|
|
|
|
Total assets acquired
|
376,613
|
|
|
|
|
|
||
|
Liabilities assumed
|
|
||
|
Accounts payable
|
(9,860
|
)
|
|
|
Other current liabilities
|
(16,535
|
)
|
|
|
Long-term income tax payable
|
(4,791
|
)
|
|
|
Deferred tax liability
|
(25,126
|
)
|
|
|
Other long-term liabilities
|
(245
|
)
|
|
|
Total liabilities assumed
|
(56,557
|
)
|
|
|
Net assets acquired including noncontrolling interest
|
320,056
|
|
|
|
Less: noncontrolling interest
|
(52,467
|
)
|
|
|
Net assets acquired
|
$
|
267,589
|
|
|
(1)
Purchased Intangible Assets
|
Useful Life
|
|
July 17, 2014
|
||
|
|
(in years)
|
|
(in thousands)
|
||
|
Core/developed technology
|
10
|
|
$
|
68,900
|
|
|
In-process technology
|
10
|
|
27,200
|
|
|
|
Customer-related
|
3
|
|
51,100
|
|
|
|
Backlog
|
1
|
|
600
|
|
|
|
Total
|
|
|
$
|
147,800
|
|
|
Assets acquired
|
|
||
|
Cash and cash equivalents
|
$
|
14,790
|
|
|
Short-term investments
|
140,984
|
|
|
|
Accounts receivable, net
|
7,047
|
|
|
|
Inventories
|
27,630
|
|
|
|
Prepaid expenses
|
1,493
|
|
|
|
Deferred tax assets
|
2,456
|
|
|
|
Other current assets
|
12,625
|
|
|
|
Property, plant and equipment, net
|
15,679
|
|
|
|
Goodwill
|
143,160
|
|
|
|
Purchased intangible assets
(1)
|
89,600
|
|
|
|
Other assets
|
325
|
|
|
|
Total assets acquired
|
455,789
|
|
|
|
|
|
||
|
Liabilities assumed
|
|
||
|
Accounts payable
|
(8,481
|
)
|
|
|
Accrued liabilities
|
(19,224
|
)
|
|
|
Long-term income tax payable
|
(3,796
|
)
|
|
|
Deferred tax liability
|
(32,511
|
)
|
|
|
Total liabilities assumed
|
(64,012
|
)
|
|
|
Net assets acquired
|
$
|
391,777
|
|
|
(1)
Purchased Intangible Assets
|
Useful Life
|
|
April 1, 2014
|
||
|
|
(in years)
|
|
(in thousands)
|
||
|
Core/developed technology
|
10
|
|
$
|
68,900
|
|
|
In-process technology
|
10
|
|
1,900
|
|
|
|
Customer-related
|
2
|
|
17,700
|
|
|
|
Backlog
|
1
|
|
1,100
|
|
|
|
Total
|
|
|
$
|
89,600
|
|
|
|
For The Years Ended March 31,
|
||||||||||
|
|
2017
|
|
2016
|
|
2015
|
||||||
|
Restructuring
|
|
|
|
|
|
||||||
|
Employee separation costs
|
$
|
39,183
|
|
|
$
|
9,577
|
|
|
$
|
2,333
|
|
|
Impairment charges
|
12,579
|
|
|
—
|
|
|
—
|
|
|||
|
Exit costs
|
44,040
|
|
|
686
|
|
|
—
|
|
|||
|
Other
|
2,806
|
|
|
900
|
|
|
507
|
|
|||
|
Legal settlement costs
|
—
|
|
|
4,294
|
|
|
—
|
|
|||
|
Insurance settlement
|
—
|
|
|
(11,500
|
)
|
|
—
|
|
|||
|
Total
|
$
|
98,608
|
|
|
$
|
3,957
|
|
|
$
|
2,840
|
|
|
|
Employee Separation Costs
|
|
Exit Costs
|
|
Total
|
||||||
|
Balance at March 31, 2015 - Restructuring Accrual
|
$
|
483
|
|
|
$
|
—
|
|
|
$
|
483
|
|
|
Charges
|
9,577
|
|
|
686
|
|
|
10,263
|
|
|||
|
Payments
|
(10,002
|
)
|
|
(686
|
)
|
|
(10,688
|
)
|
|||
|
Balance at March 31, 2016 - Restructuring Accrual
|
58
|
|
|
—
|
|
|
58
|
|
|||
|
Additions due to Atmel acquisition
|
6,277
|
|
|
—
|
|
|
6,277
|
|
|||
|
Charges
|
39,183
|
|
|
44,040
|
|
|
83,223
|
|
|||
|
Payments
|
(38,893
|
)
|
|
(6,958
|
)
|
|
(45,851
|
)
|
|||
|
Non-cash - Other
|
(479
|
)
|
|
(2,331
|
)
|
|
(2,810
|
)
|
|||
|
Changes in foreign exchange rates
|
(672
|
)
|
|
—
|
|
|
(672
|
)
|
|||
|
Balance at March 31, 2017 - Restructuring Accrual
|
$
|
5,474
|
|
|
$
|
34,751
|
|
|
$
|
40,225
|
|
|
|
Available-for-sale Securities
|
||||||||||||||
|
|
Adjusted
Cost
|
|
Gross
Unrealized
Gains
|
|
Gross
Unrealized
Losses
|
|
Estimated
Fair Value
|
||||||||
|
Government agency bonds
|
$
|
227,089
|
|
|
$
|
3
|
|
|
$
|
(227
|
)
|
|
$
|
226,865
|
|
|
Municipal bonds - tax exempt
|
55,289
|
|
|
—
|
|
|
(10
|
)
|
|
55,279
|
|
||||
|
Municipal bonds
|
10,000
|
|
|
43
|
|
|
—
|
|
|
10,043
|
|
||||
|
Corporate bonds and debt
|
207,888
|
|
|
53
|
|
|
(169
|
)
|
|
207,772
|
|
||||
|
Marketable equity securities
|
707
|
|
|
879
|
|
|
—
|
|
|
1,586
|
|
||||
|
Total
|
$
|
500,973
|
|
|
$
|
978
|
|
|
$
|
(406
|
)
|
|
$
|
501,545
|
|
|
|
Available-for-sale Securities
|
||||||||||||||
|
|
Adjusted
Cost
|
|
Gross
Unrealized
Gains
|
|
Gross
Unrealized
Losses
|
|
Estimated
Fair Value
|
||||||||
|
Government agency bonds
|
$
|
468,290
|
|
|
$
|
439
|
|
|
$
|
(99
|
)
|
|
$
|
468,630
|
|
|
Corporate bonds and debt
|
1,000
|
|
|
—
|
|
|
—
|
|
|
1,000
|
|
||||
|
Marketable equity securities
|
2,195
|
|
|
8
|
|
|
—
|
|
|
2,203
|
|
||||
|
Total
|
$
|
471,485
|
|
|
$
|
447
|
|
|
$
|
(99
|
)
|
|
$
|
471,833
|
|
|
|
March 31, 2017
|
||||||||||||||||||||||
|
|
Less than 12 Months
|
|
12 Months or Greater
|
|
Total
|
||||||||||||||||||
|
|
Fair Value
|
|
Unrealized Loss
|
|
Fair Value
|
|
Unrealized Loss
|
|
Fair Value
|
|
Unrealized Loss
|
||||||||||||
|
Government agency bonds
|
$
|
196,875
|
|
|
$
|
(227
|
)
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
196,875
|
|
|
$
|
(227
|
)
|
|
Municipal bonds - tax exempt
|
55,279
|
|
|
(10
|
)
|
|
—
|
|
|
—
|
|
|
55,279
|
|
|
(10
|
)
|
||||||
|
Corporate bonds and debt
|
132,820
|
|
|
(169
|
)
|
|
—
|
|
|
—
|
|
|
132,820
|
|
|
(169
|
)
|
||||||
|
Total
|
$
|
384,974
|
|
|
$
|
(406
|
)
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
384,974
|
|
|
$
|
(406
|
)
|
|
|
March 31, 2016
|
||||||||||||||||||||||
|
|
Less than 12 Months
|
|
12 Months or Greater
|
|
Total
|
||||||||||||||||||
|
|
Fair Value
|
|
Unrealized Loss
|
|
Fair Value
|
|
Unrealized Loss
|
|
Fair Value
|
|
Unrealized Loss
|
||||||||||||
|
Government agency bonds
|
$
|
148,562
|
|
|
$
|
(99
|
)
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
148,562
|
|
|
$
|
(99
|
)
|
|
|
Adjusted
Cost
|
|
Gross
Unrealized
Gains
|
|
Gross
Unrealized
Losses
|
|
Estimated
Fair Value
|
||||||||
|
Available-for-sale
|
|
|
|
|
|
|
|
||||||||
|
Due in one year or less
|
$
|
342,673
|
|
|
$
|
15
|
|
|
$
|
(188
|
)
|
|
$
|
342,500
|
|
|
Due after one year and through five years
|
157,594
|
|
|
84
|
|
|
(219
|
)
|
|
157,459
|
|
||||
|
Due after five years and through ten years
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||
|
Due after ten years
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||
|
Total
|
$
|
500,267
|
|
|
$
|
99
|
|
|
$
|
(407
|
)
|
|
$
|
499,959
|
|
|
|
Adjusted
Cost
|
|
Gross
Unrealized
Gains
|
|
Gross
Unrealized
Losses
|
|
Estimated
Fair Value
|
||||||||
|
Available-for-sale
|
|
|
|
|
|
|
|
||||||||
|
Due in one year or less
|
$
|
41,078
|
|
|
$
|
5
|
|
|
$
|
(5
|
)
|
|
$
|
41,078
|
|
|
Due after one year and through five years
|
428,212
|
|
|
434
|
|
|
(94
|
)
|
|
428,552
|
|
||||
|
Due after five years and through ten years
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||
|
Due after ten years
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||
|
Total
|
$
|
469,290
|
|
|
$
|
439
|
|
|
$
|
(99
|
)
|
|
$
|
469,630
|
|
|
Level 1-
|
Observable inputs such as quoted prices in active markets;
|
|
Level 2-
|
Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and
|
|
Level 3-
|
Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions.
|
|
|
Quoted Prices
in Active
Markets for
Identical
Instruments
(Level 1)
|
|
Significant
Other
Observable
Inputs
(Level 2)
|
|
Total
Balance
|
||||||
|
Assets
|
|
|
|
|
|
||||||
|
Cash and cash equivalents:
|
|
|
|
|
|
||||||
|
Money market mutual funds
|
$
|
343,815
|
|
|
$
|
—
|
|
|
$
|
343,815
|
|
|
Deposit accounts
|
—
|
|
|
564,869
|
|
|
564,869
|
|
|||
|
Short-term investments:
|
|
|
|
|
|
||||||
|
Marketable equity securities
|
1,586
|
|
|
—
|
|
|
1,586
|
|
|||
|
Corporate bonds and debt
|
—
|
|
|
165,207
|
|
|
165,207
|
|
|||
|
Government agency bonds
|
—
|
|
|
161,973
|
|
|
161,973
|
|
|||
|
Municipal bonds - tax exempt
|
—
|
|
|
55,279
|
|
|
55,279
|
|
|||
|
Municipal bonds
|
—
|
|
|
10,043
|
|
|
10,043
|
|
|||
|
Long-term investments:
|
|
|
|
|
|
||||||
|
Corporate bonds and debt
|
—
|
|
|
42,565
|
|
|
42,565
|
|
|||
|
Government agency bonds
|
—
|
|
|
64,892
|
|
|
64,892
|
|
|||
|
Total assets measured at fair value
|
$
|
345,401
|
|
|
$
|
1,064,828
|
|
|
$
|
1,410,229
|
|
|
|
Quoted Prices
in Active
Markets for
Identical
Instruments
(Level 1)
|
|
Significant
Other
Observable
Inputs
(Level 2)
|
|
Total
Balance
|
||||||
|
Assets
|
|
|
|
|
|
||||||
|
Cash and cash equivalents:
|
|
|
|
|
|
||||||
|
Money market mutual funds
|
$
|
1,787,446
|
|
|
$
|
—
|
|
|
$
|
1,787,446
|
|
|
Deposit accounts
|
—
|
|
|
305,305
|
|
|
305,305
|
|
|||
|
Short-term investments:
|
|
|
|
|
|
||||||
|
Marketable equity securities
|
2,203
|
|
|
—
|
|
|
2,203
|
|
|||
|
Corporate bonds and debt
|
—
|
|
|
1,000
|
|
|
1,000
|
|
|||
|
Government agency bonds
|
—
|
|
|
350,081
|
|
|
350,081
|
|
|||
|
Long-term investments:
|
|
|
|
|
|
||||||
|
Government agency bonds
|
—
|
|
|
118,549
|
|
|
118,549
|
|
|||
|
Total assets measured at fair value
|
$
|
1,789,649
|
|
|
$
|
774,935
|
|
|
$
|
2,564,584
|
|
|
Year ended March 31, 2016
|
Auction Rate
Securities
|
|
Corporate
Debt
|
|
Total Gains (Losses)
|
||||||
|
Balance at March 31, 2015
|
$
|
9,825
|
|
|
$
|
6,190
|
|
|
$
|
—
|
|
|
Total gains (losses) (realized):
|
|
|
|
|
|
||||||
|
Included in earnings
|
2,780
|
|
|
(3,995
|
)
|
|
(1,215
|
)
|
|||
|
Purchases, sales, issuances, and settlements, net
|
(12,605
|
)
|
|
—
|
|
|
—
|
|
|||
|
Transfers out of Level 3
|
—
|
|
|
(2,195
|
)
|
|
—
|
|
|||
|
Balance at March 31, 2016
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
(1,215
|
)
|
|
|
March 31,
|
||||||||||||||
|
|
2017
|
|
2016
|
||||||||||||
|
|
Carrying Amount
|
|
Fair Value
|
|
Carrying Amount
|
|
Fair Value
|
||||||||
|
2017 Senior Debt
|
$
|
1,384,914
|
|
|
$
|
2,106,225
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
2015 Senior Debt
|
$
|
1,261,787
|
|
|
$
|
2,481,708
|
|
|
$
|
1,216,313
|
|
|
$
|
1,762,088
|
|
|
2017 Junior Debt
|
$
|
262,298
|
|
|
$
|
586,609
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
2007 Junior Debt
|
$
|
49,952
|
|
|
$
|
445,142
|
|
|
$
|
193,936
|
|
|
$
|
1,143,117
|
|
|
|
March 31,
|
||||||
|
|
2017
|
|
2016
|
||||
|
Trade accounts receivable
|
$
|
473,238
|
|
|
$
|
289,013
|
|
|
Other
|
7,219
|
|
|
3,710
|
|
||
|
Total accounts receivable, gross
|
480,457
|
|
|
292,723
|
|
||
|
Less allowance for doubtful accounts
|
2,084
|
|
|
2,540
|
|
||
|
Total accounts receivable, net
|
$
|
478,373
|
|
|
$
|
290,183
|
|
|
|
March 31,
|
||||||
|
|
2017
|
|
2016
|
||||
|
Raw materials
|
$
|
14,430
|
|
|
$
|
12,179
|
|
|
Work in process
|
268,281
|
|
|
208,283
|
|
||
|
Finished goods
|
134,491
|
|
|
86,353
|
|
||
|
Total inventories
|
$
|
417,202
|
|
|
$
|
306,815
|
|
|
|
March 31,
|
||||||
|
|
2017
|
|
2016
|
||||
|
Land
|
$
|
73,447
|
|
|
$
|
63,907
|
|
|
Building and building improvements
|
499,668
|
|
|
458,379
|
|
||
|
Machinery and equipment
|
1,774,920
|
|
|
1,645,617
|
|
||
|
Projects in process
|
104,318
|
|
|
99,370
|
|
||
|
Total property, plant and equipment, gross
|
2,452,353
|
|
|
2,267,273
|
|
||
|
Less accumulated depreciation and amortization
|
1,769,015
|
|
|
1,657,877
|
|
||
|
Total property, plant and equipment, net
|
$
|
683,338
|
|
|
$
|
609,396
|
|
|
|
March 31, 2017
|
||
|
Net sales
|
$
|
18,334
|
|
|
Cost of sales
|
15,841
|
|
|
|
Operating expenses
|
10,650
|
|
|
|
Gain on Sale
|
643
|
|
|
|
Income tax benefit
|
(1,561
|
)
|
|
|
Net loss from discontinued operations
|
$
|
(5,953
|
)
|
|
|
|
March 31, 2017
|
||||||||||
|
|
|
Gross Amount
|
|
Accumulated Amortization
|
|
Net Amount
|
||||||
|
Core and developed technology
|
|
$
|
1,932,329
|
|
|
$
|
(419,468
|
)
|
|
$
|
1,512,861
|
|
|
Customer-related
|
|
716,945
|
|
|
(123,616
|
)
|
|
593,329
|
|
|||
|
Trademarks and trade names
|
|
11,700
|
|
|
(9,636
|
)
|
|
2,064
|
|
|||
|
In-process research and development
|
|
38,511
|
|
|
—
|
|
|
38,511
|
|
|||
|
Distribution rights
|
|
5,578
|
|
|
(5,346
|
)
|
|
232
|
|
|||
|
Other
|
|
1,449
|
|
|
(354
|
)
|
|
1,095
|
|
|||
|
Total
|
|
$
|
2,706,512
|
|
|
$
|
(558,420
|
)
|
|
$
|
2,148,092
|
|
|
|
|
March 31, 2016
|
||||||||||
|
|
|
Gross Amount
|
|
Accumulated Amortization
|
|
Net Amount
|
||||||
|
Core and developed technology
|
|
$
|
724,883
|
|
|
$
|
(255,460
|
)
|
|
$
|
469,423
|
|
|
Customer-related
|
|
278,542
|
|
|
(200,331
|
)
|
|
78,211
|
|
|||
|
Trademarks and trade names
|
|
11,700
|
|
|
(7,571
|
)
|
|
4,129
|
|
|||
|
In-process technology research and development
|
|
54,308
|
|
|
—
|
|
|
54,308
|
|
|||
|
Distribution rights
|
|
5,580
|
|
|
(5,302
|
)
|
|
278
|
|
|||
|
Total
|
|
$
|
1,075,013
|
|
|
$
|
(468,664
|
)
|
|
$
|
606,349
|
|
|
Fiscal Year Ending
March 31,
|
Projected Amortization
Expense
|
|
2018
|
$490,382
|
|
2019
|
361,988
|
|
2020
|
313,288
|
|
2021
|
256,930
|
|
2022
|
189,881
|
|
|
Semiconductor Products
Reporting Unit
|
|
Technology
Licensing
Reporting Unit
|
||||
|
Balance at March 31, 2015
|
$
|
552,071
|
|
|
$
|
19,200
|
|
|
Additions due to the acquisition of Micrel
|
440,992
|
|
|
—
|
|
||
|
Adjustments due to the acquisition of ISSC
|
389
|
|
|
—
|
|
||
|
Balance at March 31, 2016
|
993,452
|
|
|
19,200
|
|
||
|
Additions due to the acquisition of Atmel
|
1,286,371
|
|
|
—
|
|
||
|
Adjustments due to the acquisition of Micrel
|
(14
|
)
|
|
—
|
|
||
|
Balance at March 31, 2017
|
$
|
2,279,809
|
|
|
$
|
19,200
|
|
|
|
Year Ended March 31,
|
||||||||||
|
|
2017
|
|
2016
|
|
2015
|
||||||
|
Pretax Income:
|
|
|
|
|
|
||||||
|
U.S.
|
$
|
(279,304
|
)
|
|
$
|
(75,515
|
)
|
|
$
|
(944
|
)
|
|
Foreign
|
369,091
|
|
|
356,808
|
|
|
346,851
|
|
|||
|
|
$
|
89,787
|
|
|
$
|
281,293
|
|
|
$
|
345,907
|
|
|
Current expense (benefit):
|
|
|
|
|
|
||||||
|
U.S. Federal
|
$
|
21,287
|
|
|
$
|
(3,966
|
)
|
|
$
|
(3,185
|
)
|
|
State
|
1,004
|
|
|
(188
|
)
|
|
(24
|
)
|
|||
|
Foreign
|
23,792
|
|
|
21,947
|
|
|
16,602
|
|
|||
|
Total current
|
$
|
46,083
|
|
|
$
|
17,793
|
|
|
$
|
13,393
|
|
|
Deferred expense (benefit):
|
|
|
|
|
|
|
|
|
|||
|
U.S. Federal
|
$
|
(114,743
|
)
|
|
$
|
(42,207
|
)
|
|
$
|
(22,641
|
)
|
|
State
|
(5,409
|
)
|
|
(1,990
|
)
|
|
(1,562
|
)
|
|||
|
Foreign
|
(6,736
|
)
|
|
(16,228
|
)
|
|
(8,608
|
)
|
|||
|
Total deferred
|
(126,888
|
)
|
|
(60,425
|
)
|
|
(32,811
|
)
|
|||
|
Total
|
$
|
(80,805
|
)
|
|
$
|
(42,632
|
)
|
|
$
|
(19,418
|
)
|
|
|
Year Ended March 31,
|
||||||||||
|
|
2017
|
|
2016
|
|
2015
|
||||||
|
Computed expected income tax provision
|
$
|
31,425
|
|
|
$
|
98,453
|
|
|
$
|
121,067
|
|
|
State income taxes, net of federal benefits
|
(4,609
|
)
|
|
(1,246
|
)
|
|
(20
|
)
|
|||
|
Research and development tax credits - current year
|
(12,852
|
)
|
|
(13,542
|
)
|
|
(9,703
|
)
|
|||
|
Research and development tax credits - prior years
|
—
|
|
|
(2,511
|
)
|
|
(1,789
|
)
|
|||
|
Foreign income taxed at lower than the federal rate
|
(105,069
|
)
|
|
(114,497
|
)
|
|
(106,939
|
)
|
|||
|
Increases related to current and prior year tax positions
|
53,695
|
|
|
14,462
|
|
|
19,769
|
|
|||
|
Decreases related to prior year tax positions
(1)
|
(36,297
|
)
|
|
(12,103
|
)
|
|
(33,100
|
)
|
|||
|
Withholding taxes
|
5,643
|
|
|
5,970
|
|
|
5,218
|
|
|||
|
Change in valuation allowance
|
1,814
|
|
|
(2,482
|
)
|
|
(14,286
|
)
|
|||
|
Intercompany prepaid tax asset amortization
|
7,931
|
|
|
(15,493
|
)
|
|
(1,089
|
)
|
|||
|
Share-based compensation
|
(24,998
|
)
|
|
—
|
|
|
—
|
|
|||
|
Other
|
2,512
|
|
|
357
|
|
|
1,454
|
|
|||
|
Total
|
$
|
(80,805
|
)
|
|
$
|
(42,632
|
)
|
|
$
|
(19,418
|
)
|
|
|
March 31,
|
||||||
|
|
2017
|
|
2016
|
||||
|
Deferred tax assets:
|
|
|
|
||||
|
Deferred income on shipments to distributors
|
$
|
55,674
|
|
|
$
|
34,830
|
|
|
Inventory valuation
|
14,608
|
|
|
12,082
|
|
||
|
Net operating loss carryforward
|
91,606
|
|
|
63,209
|
|
||
|
Capital loss carryforward
|
12,927
|
|
|
5,707
|
|
||
|
Share-based compensation
|
42,547
|
|
|
31,410
|
|
||
|
Income tax credits
|
243,049
|
|
|
100,294
|
|
||
|
Property, plant and equipment
|
59,700
|
|
|
16,262
|
|
||
|
Accrued expenses and other
|
110,347
|
|
|
37,292
|
|
||
|
Gross deferred tax assets
|
630,458
|
|
|
301,086
|
|
||
|
Valuation allowances
|
(210,120
|
)
|
|
(161,834
|
)
|
||
|
Deferred tax assets, net of valuation allowances
|
420,338
|
|
|
139,252
|
|
||
|
Deferred tax liabilities:
|
|
|
|
|
|
||
|
Convertible debt
|
(606,674
|
)
|
|
(496,626
|
)
|
||
|
Intangible assets
|
(147,543
|
)
|
|
(20,597
|
)
|
||
|
Other
|
(6,296
|
)
|
|
(6,416
|
)
|
||
|
Deferred tax liabilities
|
(760,513
|
)
|
|
(523,639
|
)
|
||
|
Net deferred tax liability
|
$
|
(340,175
|
)
|
|
$
|
(384,387
|
)
|
|
|
|
|
|
||||
|
Reported as:
|
|
|
|
||||
|
Non-current deferred tax assets
|
$
|
68,870
|
|
|
$
|
14,831
|
|
|
Non-current deferred tax liability
|
(409,045
|
)
|
|
(399,218
|
)
|
||
|
Net deferred tax liability
|
$
|
(340,175
|
)
|
|
$
|
(384,387
|
)
|
|
|
Year Ended March 31,
|
||||||||||
|
|
2017
|
|
2016
|
|
2015
|
||||||
|
Beginning balance
|
$
|
220,669
|
|
|
$
|
170,654
|
|
|
$
|
149,878
|
|
|
Increases related to acquisitions
|
193,297
|
|
|
46,245
|
|
|
8,381
|
|
|||
|
Decreases related to settlements with tax authorities
|
(11,729
|
)
|
|
(7,954
|
)
|
|
(20,197
|
)
|
|||
|
Decreases related to statute of limitation expirations
|
(7,556
|
)
|
|
(4,591
|
)
|
|
(9,031
|
)
|
|||
|
Increases related to current year tax positions
|
26,332
|
|
|
16,315
|
|
|
23,179
|
|
|||
|
Decreases/Increases related to prior year tax positions
|
(22,536
|
)
|
|
—
|
|
|
18,444
|
|
|||
|
Ending balance
|
$
|
398,477
|
|
|
$
|
220,669
|
|
|
$
|
170,654
|
|
|
|
|
Coupon Interest Rate
|
|
Effective Interest Rate
|
|
Fair Value of Liability Component at Issuance
(1)
|
|
March 31,
|
||||||
|
|
|
|
|
|
2017
|
|
2016
|
|||||||
|
Senior Indebtedness
|
|
|
|
|
|
|
|
|
|
|
||||
|
Credit Facility
|
|
|
|
|
|
|
|
$
|
—
|
|
|
$
|
1,052.0
|
|
|
Senior Subordinated Convertible Debt
|
|
|
|
|
|
|
|
|
|
|
||||
|
2017 Senior Debt, maturing February 15, 2027
|
|
1.625%
|
|
6.0%
|
|
$1,396.3
|
|
$
|
2,070.0
|
|
|
$
|
—
|
|
|
2015 Senior Debt, maturing February 15, 2025
|
|
1.625%
|
|
5.9%
|
|
1,160.1
|
|
1,725.0
|
|
|
1,725.0
|
|
||
|
Junior Subordinated Convertible Debt
|
|
|
|
|
|
|
|
|
|
|
||||
|
2017 Junior Debt, maturing February 15, 2037
|
|
2.250%
|
|
7.5%
|
|
264.8
|
|
575.0
|
|
|
—
|
|
||
|
2007 Junior Debt, maturing December 15, 2037
|
|
2.125%
|
|
9.1%
|
|
41.0
|
|
143.8
|
|
|
575.0
|
|
||
|
Total Convertible Debt
|
|
|
|
|
|
|
|
4,513.8
|
|
|
2,300.0
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Gross long-term debt including current maturities
|
|
|
|
|
|
|
|
4,513.8
|
|
|
3,352.0
|
|
||
|
Less: Debt discount
(2)
|
|
|
|
|
|
|
|
(1,516.5
|
)
|
|
(869.0
|
)
|
||
|
Less: Debt issuance costs
(3)
|
|
|
|
|
|
|
|
(46.8
|
)
|
|
(29.6
|
)
|
||
|
Net long-term debt including current maturities
|
|
|
|
|
|
|
|
2,950.5
|
|
|
2,453.4
|
|
||
|
Less: Current maturities
(4)
|
|
|
|
|
|
|
|
(50.0
|
)
|
|
—
|
|
||
|
Net long-term debt
|
|
|
|
|
|
|
|
$
|
2,900.5
|
|
|
$
|
2,453.4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
March 31,
|
||||||
|
|
2017
|
|
2016
|
||||
|
2017 Senior Debt
|
$
|
(667.5
|
)
|
|
$
|
—
|
|
|
2015 Senior Debt
|
(446.6
|
)
|
|
(490.3
|
)
|
||
|
2017 Junior Debt
|
(309.3
|
)
|
|
—
|
|
||
|
2007 Junior Debt
|
(93.1
|
)
|
|
(378.7
|
)
|
||
|
Total unamortized discount
|
$
|
(1,516.5
|
)
|
|
$
|
(869.0
|
)
|
|
|
March 31,
|
||||||
|
|
2017
|
|
2016
|
||||
|
Senior Credit Facility
|
$
|
(8.5
|
)
|
|
$
|
(8.8
|
)
|
|
2017 Senior Debt
|
(17.6
|
)
|
|
—
|
|
||
|
2015 Senior Debt
|
(16.6
|
)
|
|
(18.4
|
)
|
||
|
2017 Junior Debt
|
(3.4
|
)
|
|
—
|
|
||
|
2007 Junior Debt
|
(0.7
|
)
|
|
(2.4
|
)
|
||
|
Total debt issuance costs
|
$
|
(46.8
|
)
|
|
$
|
(29.6
|
)
|
|
|
Dividend adjusted rates as of March 31, 2017
|
|||||||||||
|
|
Conversion Rate, adjusted
|
|
Conversion Price, adjusted
|
|
Maximum Incremental Rate, adjusted
|
|
Maximum Conversion Rate, adjusted
|
|||||
|
2017 Senior Debt
|
9.9435
|
|
|
$
|
100.57
|
|
|
4.9718
|
|
|
14.1695
|
|
|
2015 Senior Debt
|
15.5063
|
|
|
$
|
64.49
|
|
|
7.7531
|
|
|
21.7087
|
|
|
2017 Junior Debt
|
10.1211
|
|
|
$
|
98.80
|
|
|
5.0606
|
|
|
14.1695
|
|
|
2007 Junior Debt
|
42.1312
|
|
|
$
|
23.74
|
|
|
NA
|
|
|
48.4509
|
|
|
|
Year Ended March 31,
|
||||||||||
|
|
2017
|
|
2016
|
|
2015
|
||||||
|
Debt issuance amortization
|
$
|
2.1
|
|
|
$
|
1.8
|
|
|
$
|
0.4
|
|
|
Amortization of debt discount - non cash interest expense
|
56.1
|
|
|
48.0
|
|
|
14.8
|
|
|||
|
Coupon interest expense
|
44.5
|
|
|
40.2
|
|
|
26.6
|
|
|||
|
Total
|
$
|
102.7
|
|
|
$
|
90.0
|
|
|
$
|
41.8
|
|
|
|
Year Ended March 31,
|
||
|
|
2017
|
||
|
Service costs
|
$
|
1,430
|
|
|
Interest costs
|
962
|
|
|
|
Settlements
|
511
|
|
|
|
Net pension period cost
|
$
|
2,903
|
|
|
Projected benefit obligation at April 4, 2016
|
$
|
40,313
|
|
|
Service cost
|
1,430
|
|
|
|
Interest cost
|
962
|
|
|
|
Settlements
|
511
|
|
|
|
Actuarial losses
|
7,969
|
|
|
|
Benefits paid
|
(440
|
)
|
|
|
Foreign currency exchange rate changes
|
(322
|
)
|
|
|
Projected benefit obligation at March 31, 2017
|
$
|
50,423
|
|
|
Accumulated benefit obligation at March 31, 2017
|
45,610
|
|
|
|
Weighted average assumed discount rate
|
1.82%
|
|
Weighted average assumed compensation rate of increase
|
2.90%
|
|
Fiscal Year Ending March 31,
|
Expected Benefit Payments
|
||
|
2018
|
$
|
700
|
|
|
2019
|
714
|
|
|
|
2020
|
1,017
|
|
|
|
2021
|
1,033
|
|
|
|
2022
|
1,549
|
|
|
|
2023 through 2027
|
8,664
|
|
|
|
Total
|
$
|
13,677
|
|
|
|
Year Ended March 31,
|
|||||||||||
|
|
2017
|
|
2016
|
|
2015
|
|
||||||
|
Cost of sales
|
$
|
18,713
|
|
(1)
|
$
|
8,252
|
|
(1)
|
$
|
9,010
|
|
(1)
|
|
Research and development
|
46,801
|
|
|
32,022
|
|
|
28,164
|
|
|
|||
|
Selling, general and administrative
|
62,641
|
|
|
31,146
|
|
|
21,422
|
|
|
|||
|
Pre-tax effect of share-based compensation
|
128,155
|
|
|
71,420
|
|
|
58,596
|
|
|
|||
|
Income tax benefit
|
44,214
|
|
(2)
|
23,012
|
|
|
10,640
|
|
|
|||
|
Net income effect of share-based compensation
|
$
|
83,941
|
|
|
$
|
48,408
|
|
|
$
|
47,956
|
|
|
|
|
Number of
Shares
|
|
Weighted Average Grant Date Fair Value
|
|||
|
Nonvested shares at March 31, 2014
|
5,530,034
|
|
|
$
|
30.13
|
|
|
Granted
|
1,446,968
|
|
|
42.02
|
|
|
|
Forfeited
|
(266,415
|
)
|
|
32.45
|
|
|
|
Vested
|
(1,441,671
|
)
|
|
26.96
|
|
|
|
Nonvested shares at March 31, 2015
|
5,268,916
|
|
|
34.15
|
|
|
|
Granted
|
2,479,729
|
|
|
38.91
|
|
|
|
Assumed upon acquisition
|
525,442
|
|
|
40.58
|
|
|
|
Forfeited
|
(360,072
|
)
|
|
38.20
|
|
|
|
Vested
|
(1,606,273
|
)
|
|
32.47
|
|
|
|
Nonvested shares at March 31, 2016
|
6,307,742
|
|
|
36.76
|
|
|
|
Granted
|
1,635,655
|
|
|
51.46
|
|
|
|
Assumed upon acquisition
|
2,059,524
|
|
|
46.57
|
|
|
|
Forfeited
|
(722,212
|
)
|
|
43.58
|
|
|
|
Vested
|
(2,861,253
|
)
|
|
38.60
|
|
|
|
Nonvested shares at March 31, 2017
|
6,419,456
|
|
|
$
|
42.06
|
|
|
|
Number of
Shares
|
|
Weighted Average Exercise Price per Share
|
|||
|
Outstanding at March 31, 2014
|
573,611
|
|
|
$
|
24.75
|
|
|
Granted
|
27,654
|
|
|
46.66
|
|
|
|
Assumed upon acquisition
|
666,586
|
|
|
29.33
|
|
|
|
Exercised
|
(477,618
|
)
|
|
26.42
|
|
|
|
Canceled
|
(105,934
|
)
|
|
28.17
|
|
|
|
Outstanding at March 31, 2015
|
684,299
|
|
|
28.41
|
|
|
|
Granted
|
244
|
|
|
41.09
|
|
|
|
Assumed upon acquisition
|
604,900
|
|
|
35.03
|
|
|
|
Exercised
|
(221,987
|
)
|
|
25.30
|
|
|
|
Canceled
|
(153,948
|
)
|
|
31.52
|
|
|
|
Outstanding at March 31, 2016
|
913,508
|
|
|
33.00
|
|
|
|
Exercised
|
(437,906
|
)
|
|
34.34
|
|
|
|
Canceled
|
(42,485
|
)
|
|
34.26
|
|
|
|
Outstanding at March 31, 2017
|
433,117
|
|
|
$
|
31.51
|
|
|
|
Year Ended March 31,
|
||||
|
|
2016
|
|
2015
|
||
|
Expected term (in years)
|
6.5
|
|
|
6.5
|
|
|
Volatility
|
29.50
|
%
|
|
26.65
|
%
|
|
Risk-free interest rate
|
1.54
|
%
|
|
1.59
|
%
|
|
Dividend yield
|
3.00
|
%
|
|
3.00
|
%
|
|
Year Ending March 31,
|
|
Amount
|
||
|
2018
|
|
$
|
26,259
|
|
|
2019
|
|
21,114
|
|
|
|
2020
|
|
14,920
|
|
|
|
2021
|
|
11,645
|
|
|
|
2022
|
|
11,038
|
|
|
|
Thereafter
|
|
2,423
|
|
|
|
Total minimum payments
|
|
$
|
87,399
|
|
|
|
Years ended March 31,
|
||||||||||||||||||||||
|
|
2017
|
|
2016
|
|
2015
|
||||||||||||||||||
|
|
Net Sales
|
|
Gross Profit
|
|
Net Sales
|
|
Gross Profit
|
|
Net Sales
|
|
Gross Profit
|
||||||||||||
|
Semiconductor products
|
$
|
3,316,651
|
|
|
$
|
1,666,040
|
|
|
$
|
2,084,210
|
|
|
$
|
1,116,340
|
|
|
$
|
2,057,443
|
|
|
$
|
1,139,971
|
|
|
Technology licensing
|
91,156
|
|
|
91,156
|
|
|
89,124
|
|
|
89,124
|
|
|
89,593
|
|
|
89,593
|
|
||||||
|
Total
|
$
|
3,407,807
|
|
|
$
|
1,757,196
|
|
|
$
|
2,173,334
|
|
|
$
|
1,205,464
|
|
|
$
|
2,147,036
|
|
|
$
|
1,229,564
|
|
|
|
March 31,
|
||||||
|
|
2017
|
|
2016
|
||||
|
United States
|
$
|
388,537
|
|
|
$
|
373,860
|
|
|
Thailand
|
210,603
|
|
|
182,813
|
|
||
|
Various other countries
|
84,198
|
|
|
52,723
|
|
||
|
Total long-lived assets
|
$
|
683,338
|
|
|
$
|
609,396
|
|
|
|
Year ended March 31,
|
||||||||||||||
|
|
2016
|
|
2015
|
||||||||||||
|
Income Statement Classification
|
Gain (Loss) on 2015 Senior Debt
|
|
Gain (Loss) on Interest Rate Swap
|
|
Gain (Loss) on 2015 Senior Debt
|
|
Gain (Loss) on Interest Rate Swap
|
||||||||
|
Other income (expense)
|
$
|
(18,060
|
)
|
|
$
|
16,345
|
|
|
$
|
(8,302
|
)
|
|
$
|
8,928
|
|
|
|
Year Ended March 31,
|
||||||||||
|
|
2017
|
|
2016
|
|
2015
|
||||||
|
Net income from continuing operations attributable to Microchip
|
$
|
170,592
|
|
|
$
|
324,132
|
|
|
$
|
369,009
|
|
|
Weighted average common shares outstanding
|
217,196
|
|
|
203,384
|
|
|
200,937
|
|
|||
|
Dilutive effect of stock options and RSUs
|
4,357
|
|
|
3,350
|
|
|
3,642
|
|
|||
|
Dilutive effect of 2007 Junior Debt
|
12,715
|
|
|
10,654
|
|
|
18,982
|
|
|||
|
Dilutive effect of 2015 Senior Debt
|
538
|
|
|
—
|
|
|
—
|
|
|||
|
Dilutive effect of 2017 Senior Debt
|
—
|
|
|
—
|
|
|
—
|
|
|||
|
Dilutive effect of 2017 Junior Debt
|
—
|
|
|
—
|
|
|
—
|
|
|||
|
Weighted average common and potential common shares outstanding
|
234,806
|
|
|
217,388
|
|
|
223,561
|
|
|||
|
Basic net income per common share from continuing operations attributable to Microchip stockholders
|
$
|
0.79
|
|
|
$
|
1.59
|
|
|
$
|
1.84
|
|
|
Diluted net income per common share from continuing operations
attributable to Microchip stockholders
|
$
|
0.73
|
|
|
$
|
1.49
|
|
|
$
|
1.65
|
|
|
|
March 31,
|
||||||||||
|
|
2017
|
|
2016
|
|
2015
|
||||||
|
2007 Junior Debt
|
$
|
24.01
|
|
|
$
|
24.73
|
|
|
$
|
25.48
|
|
|
2015 Senior Debt
|
$
|
65.21
|
|
|
$
|
67.19
|
|
|
$
|
68.25
|
|
|
2017 Senior Debt
|
$
|
100.58
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
2017 Junior Debt
|
$
|
98.81
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
Fiscal 2017
|
|
First
Quarter
|
|
Second
Quarter
|
|
Third
Quarter
|
|
Fourth
Quarter
|
|
Total
|
||||||||||
|
Net sales
|
|
$
|
799,411
|
|
|
$
|
871,364
|
|
|
$
|
834,366
|
|
|
$
|
902,666
|
|
|
$
|
3,407,807
|
|
|
Gross profit
|
|
348,490
|
|
|
410,621
|
|
|
465,259
|
|
|
532,826
|
|
|
1,757,196
|
|
|||||
|
Operating income
|
|
(59,104
|
)
|
|
62,760
|
|
|
118,074
|
|
|
154,087
|
|
|
275,817
|
|
|||||
|
Net income
|
|
(113,363
|
)
|
|
33,919
|
|
|
107,175
|
|
|
136,908
|
|
|
164,639
|
|
|||||
|
Diluted net income per common share attributable to Microchip stockholders
|
|
(0.53
|
)
|
|
0.14
|
|
|
0.46
|
|
|
0.57
|
|
|
0.71
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Fiscal 2016
|
|
First
Quarter
|
|
Second
Quarter
|
|
Third
Quarter
|
|
Fourth
Quarter
|
|
Total
|
||||||||||
|
Net sales
|
|
$
|
533,952
|
|
|
$
|
541,391
|
|
|
$
|
540,344
|
|
|
$
|
557,647
|
|
|
$
|
2,173,334
|
|
|
Gross profit
|
|
309,017
|
|
|
300,950
|
|
|
292,718
|
|
|
302,779
|
|
|
1,205,464
|
|
|||||
|
Operating income
|
|
121,319
|
|
|
74,948
|
|
|
76,132
|
|
|
79,946
|
|
|
352,345
|
|
|||||
|
Net income
|
|
130,460
|
|
|
64,899
|
|
|
61,211
|
|
|
67,355
|
|
|
323,925
|
|
|||||
|
Less: Net loss attributable to noncontrolling interests
|
|
207
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
207
|
|
|||||
|
Net income attributable to Microchip Technology
|
|
130,667
|
|
|
64,899
|
|
|
61,211
|
|
|
67,355
|
|
|
324,132
|
|
|||||
|
Diluted net income per common share attributable to Microchip stockholders
|
|
0.60
|
|
|
0.30
|
|
|
0.28
|
|
|
0.31
|
|
|
1.49
|
|
|||||
|
|
Balance at Beginning
of Year
|
|
Additions Charged to Costs and Expenses
|
|
Additions Charged to Other Accounts
|
|
Deductions
|
|
Balance at End of Year
|
||||||||||
|
Valuation allowance for deferred tax assets:
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Fiscal Year 2017
|
$
|
161,834
|
|
|
$
|
15,220
|
|
|
$
|
37,578
|
|
|
$
|
(4,512
|
)
|
|
$
|
210,120
|
|
|
Fiscal Year 2016
|
116,482
|
|
|
5,535
|
|
|
47,834
|
|
|
(8,017
|
)
|
|
161,834
|
|
|||||
|
Fiscal Year 2015
|
93,811
|
|
|
—
|
|
|
36,957
|
|
|
(14,286
|
)
|
|
116,482
|
|
|||||
|
|
Balance at Beginning
of Year
|
|
Additions Charged to Costs and
Expenses
|
|
Deductions
(1)
|
|
Balance at End of Year
|
||||||||
|
Allowance for doubtful accounts:
|
|
|
|
|
|
|
|
||||||||
|
Fiscal Year 2017
|
$
|
2,540
|
|
|
$
|
184
|
|
|
$
|
(640
|
)
|
|
$
|
2,084
|
|
|
Fiscal Year 2016
|
2,621
|
|
|
59
|
|
|
(140
|
)
|
|
2,540
|
|
||||
|
Fiscal Year 2015
|
2,918
|
|
|
104
|
|
|
(401
|
)
|
|
2,621
|
|
||||
|
Year ended March 31, 2017
|
Unrealized Holding Gains (Losses) Available-for-sale Securities
|
|
Minimum Pension Liability
|
|
Foreign Currency
|
|
Total
|
||||||||
|
Balance at March 31, 2016
|
$
|
348
|
|
|
$
|
44
|
|
|
$
|
(3,749
|
)
|
|
$
|
(3,357
|
)
|
|
Other comprehensive loss before reclassifications
|
(1,558
|
)
|
|
(5,307
|
)
|
|
(5,678
|
)
|
|
(12,543
|
)
|
||||
|
Amounts reclassified from accumulated other comprehensive income (loss)
|
1,522
|
|
|
—
|
|
|
—
|
|
|
1,522
|
|
||||
|
Net other comprehensive loss
|
(36
|
)
|
|
(5,307
|
)
|
|
(5,678
|
)
|
|
(11,021
|
)
|
||||
|
Balance at March 31, 2017
|
$
|
312
|
|
|
$
|
(5,263
|
)
|
|
$
|
(9,427
|
)
|
|
$
|
(14,378
|
)
|
|
Year ended March 31, 2016
|
Unrealized Holding Gains (Losses) Available-for-sale Securities
|
|
Minimum Pension Liability
|
|
Foreign Currency
|
|
Total
|
||||||||
|
Balance at March 31, 2015
|
$
|
14,537
|
|
|
$
|
13
|
|
|
$
|
(3,474
|
)
|
|
$
|
11,076
|
|
|
Other comprehensive (loss) income before reclassifications
|
(3,241
|
)
|
|
31
|
|
|
—
|
|
|
(3,210
|
)
|
||||
|
Amounts reclassified from accumulated other comprehensive income (loss)
|
(10,948
|
)
|
|
—
|
|
|
—
|
|
|
(10,948
|
)
|
||||
|
Net other comprehensive income (loss)
|
(14,189
|
)
|
|
31
|
|
|
—
|
|
|
(14,158
|
)
|
||||
|
Purchase of shares from noncontrolling interest
|
—
|
|
|
—
|
|
|
(275
|
)
|
|
(275
|
)
|
||||
|
Balance at March 31, 2016
|
$
|
348
|
|
|
$
|
44
|
|
|
$
|
(3,749
|
)
|
|
$
|
(3,357
|
)
|
|
|
Year ended March 31,
|
|
|
||||||||||
|
Description of AOCI Component
|
2017
|
|
2016
|
|
2015
|
|
Related Statement of Income Line
|
||||||
|
Unrealized (losses) gains on available-for-sale securities
|
$
|
(1,522
|
)
|
|
$
|
10,948
|
|
|
$
|
18,706
|
|
|
Other income, net
|
|
Taxes
|
—
|
|
|
—
|
|
|
(12
|
)
|
|
Provision for income taxes
|
|||
|
Reclassification of realized transactions, net of taxes
|
$
|
(1,522
|
)
|
|
$
|
10,948
|
|
|
$
|
18,694
|
|
|
Net Income
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|